Palantir (PLTR) 10-Q 13 Nov 20 2020 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Sep. 30, 2020	Nov. 06, 2020
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q3
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes
Entity Registrant Name	Palantir Technologies Inc.
Entity Central Index Key	0001321655
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	No
Entity Shell Company	false
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Incorporation, State or Country Code	DE
Entity Address, City or Town	Denver
Entity Address, State or Province	CO
Title of 12(b) Security	Class A Common Stock, par value $0.001 per share
Trading Symbol	PLTR
Security Exchange Name	NYSE
Common Class A [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		1,471,832,735
Common Class B [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		269,207,902
Common Class F [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		1,005,000

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands		Sep. 30, 2020	Dec. 31, 2019
Current assets:
Cash and cash equivalents		$ 1,800,190	$ 1,079,154
Restricted cash		43,800	52,099
Accounts receivable		162,269	50,315
Prepaid expenses and other current assets		388,165	32,585
Total current assets		2,394,424	1,214,153
Property and equipment, net		29,369	31,589
Restricted cash, noncurrent		86,343	270,709
Other assets		93,576	77,574
Total assets		2,603,712	1,594,025
Current liabilities:
Accounts payable		22,221	51,735
Accrued liabilities		466,999	126,620
Deferred revenue	[1]	172,066	186,105
Customer deposits		280,901	364,138
Total current liabilities		942,187	728,598
Deferred revenue, noncurrent	[1]	67,064	77,030
Customer deposits, noncurrent		102,231	167,538
Debt, noncurrent, net		197,753	396,065
Other noncurrent liabilities		42,724	78,205
Total liabilities		1,351,959	1,447,436
Commitments and Contingencies (Note 8)
Stockholders' equity (deficit):
Preferred stock
Common stock		1,727	588
Additional paid-in capital		6,065,869	1,857,331
Treasury stock			(38,895)
Accumulated other comprehensive income (loss)		1,168	(703)
Accumulated deficit		(4,817,011)	(3,798,963)
Total stockholders' equity (deficit)		1,251,753	(1,980,642)
Total liabilities, redeemable convertible and convertible preferred stock, and stockholders' equity (deficit)		$ 2,603,712	1,594,025
Redeemable Convertible Preferred Stock [Member]
Temporary equity
Convertible preferred stock			33,569
Nonredeemable Convertible Preferred Stock [Member]
Temporary equity
Convertible preferred stock			$ 2,093,662
[1]	Deferred revenue as of September 30, 2020 and December 31, 2019 includes $71.0 million and $75.0 million, respectively, from Palantir Technologies Japan, K.K. See Note 6, Equity Method Investments, for more information.

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	2,000,000,000	0
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, shares authorized	22,701,005,000	4,000,000,000
Common stock, shares issued	1,726,685,755	587,889,687
Common stock, shares outstanding	1,726,685,755	581,497,116
Treasury stock, shares	0	6,392,571
Deferred revenue	$ 71,000	$ 75,000
Redeemable Convertible Preferred Stock [Member]
Temporary equity, par value	$ 0.001	$ 0.001
Temporary equity, shares authorized	0	35,002,700
Temporary equity, shares issued	0	4,017,378
Temporary equity, shares outstanding	0	4,017,378
Temporary equity, liquidation preference	$ 0	$ 14,101
Nonredeemable Convertible Preferred Stock [Member]
Temporary equity, par value	$ 0.001	$ 0.001
Temporary equity, shares authorized	0	877,442,966
Temporary equity, shares issued	0	742,839,990
Temporary equity, shares outstanding	0	742,839,990
Temporary equity, liquidation preference	$ 0	$ 2,102,556
Class A Common Stock [Member]
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	20,000,000,000	2,200,000,000
Common stock, shares issued	1,320,584,721	315,615,753
Common stock, shares outstanding	1,320,584,721	309,223,182
Class B Common Stock [Member]
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	2,700,000,000	1,800,000,000
Common stock, shares issued	405,096,034	272,273,934
Common stock, shares outstanding	405,096,034	272,273,934
Class F Common Stock [Member]
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	1,005,000	0
Common stock, shares issued	1,005,000	0
Common stock, shares outstanding	1,005,000	0

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Income Statement [Abstract]
Revenue	$ 289,366	$ 190,541	$ 770,582	$ 513,197
Cost of revenue	149,340	65,073	282,044	166,471
Gross profit	140,026	125,468	488,538	346,726
Operating expenses:
Sales and marketing	334,911	119,666	536,082	337,255
Research and development	313,915	75,880	466,530	229,728
General and administrative	338,977	74,062	503,033	208,736
Total operating expenses	987,803	269,608	1,505,645	775,719
Loss from operations	(847,777)	(144,140)	(1,017,107)	(428,993)
Interest income	494	3,390	4,312	12,953
Interest expense	(2,085)	(173)	(12,325)	(395)
Change in fair value of warrants	(9,201)	784	811	2,743
Other income (expense), net	(3,293)	2,305	1,218	1,858
Loss before provision (benefit) for income taxes	(861,862)	(137,834)	(1,023,091)	(411,834)
Provision (benefit) for income taxes	(8,543)	2,026	(5,043)	8,485
Net loss	$ (853,319)	$ (139,860)	$ (1,018,048)	$ (420,319)
Net loss per share attributable to common stockholders, basic	$ (0.94)	$ (0.24)	$ (1.43)	$ (0.73)
Net loss per share attributable to common stockholders, diluted	$ (0.94)	$ (0.24)	$ (1.43)	$ (0.73)
Weighted-average shares of common stock outstanding used in computing net loss per share attributable to common stockholders, basic	905,462,010	580,104,846	713,879,104	574,342,061
Weighted-average shares of common stock outstanding used in computing net loss per share attributable to common stockholders, diluted	905,462,010	580,104,846	716,027,459	574,342,061

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Statement of Comprehensive Income [Abstract]
Net loss	$ (853,319)	$ (139,860)	$ (1,018,048)	$ (420,319)
Other comprehensive income (loss):
Foreign currency translation adjustments	268	(5,133)	1,871	(470)
Comprehensive loss	$ (853,051)	$ (144,993)	$ (1,016,177)	$ (420,789)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Redeemable Convertible and Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Cumulative effect of Accounting Changes [Member]	Series H-1 Convertible Preferred Stock [Member]	Series F Convertible Stock [Member]	Series D Convertible Stock [Member]	Common Stock [Member]	Common Stock [Member]Series H-1 Convertible Preferred Stock [Member]	Common Stock [Member]Series F Convertible Stock [Member]	Common Stock [Member]Series D Convertible Stock [Member]	Additional Paid-in Capital [Member]	Additional Paid-in Capital [Member]Cumulative effect of Accounting Changes [Member]	Additional Paid-in Capital [Member]Series H-1 Convertible Preferred Stock [Member]	Additional Paid-in Capital [Member]Series F Convertible Stock [Member]	Additional Paid-in Capital [Member]Series D Convertible Stock [Member]	Treasury Stock [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Retained Earnings [Member]	Retained Earnings [Member]Cumulative effect of Accounting Changes [Member]	Redeemable Convertible Preferred Stock [Member]	Redeemable Convertible Preferred Stock [Member]Series H Redeemable Convertible Preferred Stock [Member]	Redeemable Convertible Preferred Stock [Member]Common Stock [Member]	Redeemable Convertible Preferred Stock [Member]Additional Paid-in Capital [Member]	Nonredeemable Convertible Preferred Stock [Member]	Nonredeemable Convertible Preferred Stock [Member]Series H-1 Convertible Preferred Stock [Member]	Nonredeemable Convertible Preferred Stock [Member]Series K Convertible Preferred Stock [Member]	Nonredeemable Convertible Preferred Stock [Member]Series H Redeemable Convertible Preferred Stock [Member]	Nonredeemable Convertible Preferred Stock [Member]Series F Convertible Stock [Member]	Nonredeemable Convertible Preferred Stock [Member]Series D Convertible Stock [Member]	Nonredeemable Convertible Preferred Stock [Member]Common Stock [Member]	Nonredeemable Convertible Preferred Stock [Member]Additional Paid-in Capital [Member]
Temporary equity, beginning period, Shares at Dec. 31, 2018																			25,947,422				742,813,372
Temporary equity, beginning period at Dec. 31, 2018																			$ 172,163				$ 2,087,560
Balance at beginning period, Shares at Dec. 31, 2018						549,367,691
Balance at beginning period at Dec. 31, 2018	$ (1,751,428)	$ 12,525				$ 570				$ 1,627,737	$ (34)				$ (148,621)	$ 762	$ (3,231,876)	$ 12,559
Balance at beginning period, treasury shares at Dec. 31, 2018															20,636,798
Repurchase of common stock, held in treasury, Shares						(1,448,687)									1,448,687
Repurchase of common stock, held in treasury	(7,073)														$ (7,073)
Issuance of common stock from the exercise of stock options, Shares						8,892,352
Issuance of common stock from the exercise of stock options	9,337					$ 9				9,328
Conversion of convertible preferred stock to common stock, Shares								10,078	30,000																		(10,078)	(30,000)
Conversion of convertible preferred stock to common stock				$ 20	$ 24								$ 20	$ 24													$ (20)	$ (24)
Issuance of Series H redeemable convertible preferred stock upon exercise of warrants, Shares																				2,949,002
Issuance of Series H redeemable convertible preferred stock upon exercise of warrants																				$ 26,069
Issuance of convertible preferred stock, Shares																				1,068,376								1,097,094
Issuance of convertible preferred stock																				$ 7,500								$ 7,375
Reclassification of redeemable convertible preferred stock into convertible preferred stock upon expiration of redemption option, Shares																				(2,015,798)						2,015,798
Reclassification of redeemable convertible preferred stock into convertible preferred stock upon expiration of redemption option																				$ (4,163)						$ 4,163
Sale of common stock, held in treasury	100,000									(20,928)					$ 120,928
Redemption of redeemable convertible preferred stock, Shares																				(23,931,624)
Redemption of redeemable convertible preferred stock																				$ (168,000)
Sale of common stock, held in treasury, Shares						16,583,747									(16,583,747)
Other comprehensive income	(470)															(470)
Stock-based compensation	164,794									164,794
Balance at end of period, Shares at Sep. 30, 2019						573,435,181
Net loss	(420,319)																(420,319)
Balance at end of period at Sep. 30, 2019	(1,892,590)					$ 579				1,780,941					$ (34,766)	292	(3,639,636)
Temporary equity, ending period, Shares at Sep. 30, 2019																			4,017,378				745,886,186
Temporary equity, ending period at Sep. 30, 2019																			$ 33,569				$ 2,099,054
Balance at end of period, treasury shares at Sep. 30, 2019															5,501,738
Temporary equity, beginning period, Shares at Jun. 30, 2019																			23,931,624				745,886,186
Temporary equity, beginning period at Jun. 30, 2019																							$ 2,099,054
Balance at beginning period, Shares at Jun. 30, 2019						571,702,167
Balance at beginning period at Jun. 30, 2019	(1,800,409)					$ 577				1,727,804					$ (34,439)	5,425	(3,499,776)
Balance at beginning period, treasury shares at Jun. 30, 2019															5,435,072
Repurchase of common stock, held in treasury, Shares						(66,666)									66,666
Repurchase of common stock, held in treasury	(327)														$ (327)
Issuance of common stock from the exercise of stock options, Shares						1,799,680
Issuance of common stock from the exercise of stock options	1,376					$ 2				1,374
Issuance of Series H redeemable convertible preferred stock upon exercise of warrants, Shares																				2,949,002
Issuance of Series H redeemable convertible preferred stock upon exercise of warrants																				$ 26,069
Issuance of convertible preferred stock, Shares																				1,068,376
Issuance of convertible preferred stock																				$ 7,500
Redemption of redeemable convertible preferred stock, Shares																				(23,931,624)
Other comprehensive income	(5,133)															(5,133)
Stock-based compensation	51,763									51,763
Balance at end of period, Shares at Sep. 30, 2019						573,435,181
Net loss	(139,860)																(139,860)
Balance at end of period at Sep. 30, 2019	(1,892,590)					$ 579				1,780,941					$ (34,766)	292	(3,639,636)
Temporary equity, ending period, Shares at Sep. 30, 2019																			4,017,378				745,886,186
Temporary equity, ending period at Sep. 30, 2019																			$ 33,569				$ 2,099,054
Balance at end of period, treasury shares at Sep. 30, 2019															5,501,738
Temporary equity, beginning period, Shares at Dec. 31, 2019																			4,017,378				742,839,990
Temporary equity, beginning period at Dec. 31, 2019																			$ 33,569				$ 2,093,662
Balance at beginning period, Shares at Dec. 31, 2019						581,497,116
Balance at beginning period at Dec. 31, 2019	$ (1,980,642)					$ 588				1,857,331					$ (38,895)	(703)	(3,798,963)
Balance at beginning period, treasury shares at Dec. 31, 2019	6,392,571														6,392,571
Repurchase of common stock, held in treasury, Shares						(808,201)									808,201
Repurchase of common stock, held in treasury	$ (3,777)														$ (3,777)
Issuance of common stock upon settlement of restricted stock units ("RSUs"), Shares						68,149,214
Issuance of common stock upon settlement of restricted stock units ("RSUs")						$ 68				(68)
Issuance of common stock from the exercise of stock options, Shares	69,444,099					69,444,099
Issuance of common stock from the exercise of stock options	$ 116,030					$ 69				115,961
Retirement of treasury stock, Shares															(7,200,772)
Retirement of treasury stock						$ (7)				(42,665)					$ 42,672
Conversion of convertible preferred stock to common stock, Shares							28,490												(4,017,378)		4,017,378		(745,312,799)	(28,490)					793,725,807
Conversion of redeemable convertible preferred stock to common stock	33,569																		$ (33,569)		$ 4	$ 33,565
Conversion of convertible preferred stock to common stock	2,105,319																						$ (2,105,319)						$ 794	$ 2,104,525
Conversion of convertible preferred stock to common stock			$ 100									$ 100												$ (100)
Issuance of common stock upon net exercise of common stock warrants, Shares						7,631,329
Issuance of common stock upon net exercise of common stock warrants						$ 8				(8)
Stock issued during period, Shares						206,500,523																			121,265
Stock issued during period	942,529					$ 207				942,322															$ 947
Issuance of convertible preferred stock, Shares																												2,380,034
Issuance of convertible preferred stock																												$ 10,810
Conversion of preferred stock warrants to common stock warrants	31,007									31,007
Settlement of employee loan accounted for as a modification to stock option (Value)	(205)					$ (4)				(201)
Settlement of employee loan accounted for as a modification to stock option (Shares)						(3,500,000)
Other comprehensive income	1,871															1,871
Stock-based compensation	1,024,000									1,024,000
Balance at end of period, Shares at Sep. 30, 2020						1,726,685,755
Net loss	(1,018,048)																(1,018,048)
Balance at end of period at Sep. 30, 2020	$ 1,251,753					$ 1,727				6,065,869						1,168	(4,817,011)
Temporary equity, ending period, Shares at Sep. 30, 2020																			0				0
Balance at end of period, treasury shares at Sep. 30, 2020	0
Temporary equity, beginning period, Shares at Jun. 30, 2020																			4,017,378				742,932,765
Temporary equity, beginning period at Jun. 30, 2020																			$ 33,569				$ 2,094,509
Balance at beginning period, Shares at Jun. 30, 2020						736,634,601
Balance at beginning period at Jun. 30, 2020	$ (1,398,701)					$ 737				2,563,354						900	(3,963,692)
Issuance of common stock upon settlement of restricted stock units ("RSUs"), Shares						68,149,214
Issuance of common stock upon settlement of restricted stock units ("RSUs")						$ 68				(68)
Issuance of common stock from the exercise of stock options, Shares						31,747,857
Issuance of common stock from the exercise of stock options	87,207					$ 32				87,175
Conversion of convertible preferred stock to common stock, Shares																			(4,017,378)		4,017,378		(745,312,799)						793,725,807
Conversion of redeemable convertible preferred stock to common stock	33,569																		$ (33,569)		$ 4	$ 33,565
Conversion of convertible preferred stock to common stock	2,105,319																						$ (2,105,319)						$ 794	$ 2,104,525
Issuance of common stock upon net exercise of common stock warrants, Shares						7,631,329
Issuance of common stock upon net exercise of common stock warrants						$ 8				(8)
Stock issued during period, Shares						88,279,569
Stock issued during period	404,679					$ 88				404,591
Issuance of convertible preferred stock, Shares																							2,380,034
Issuance of convertible preferred stock																							$ 10,810
Conversion of preferred stock warrants to common stock warrants	31,007									31,007
Settlement of employee loan accounted for as a modification to stock option (Value)	(205)					$ (4)				(201)
Settlement of employee loan accounted for as a modification to stock option (Shares)						(3,500,000)
Other comprehensive income	268															268
Stock-based compensation	841,929									841,929
Balance at end of period, Shares at Sep. 30, 2020						1,726,685,755
Net loss	(853,319)																(853,319)
Balance at end of period at Sep. 30, 2020	$ 1,251,753					$ 1,727				$ 6,065,869						$ 1,168	$ (4,817,011)
Temporary equity, ending period, Shares at Sep. 30, 2020																			0				0
Balance at end of period, treasury shares at Sep. 30, 2020	0

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Operating activities
Net loss	$ (1,018,048)	$ (420,319)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	10,308	9,450
Stock-based compensation	1,028,914	164,650
Amortization of debt issuance costs	2,319	87
Change in fair value of warrants	(811)	(2,743)
Loss from equity method investments	1,439
Impairment of assets	674
Changes in operating assets and liabilities:
Accounts receivable	(112,723)	(96,142)
Prepaid expenses and other current assets	(16,434)	(8,045)
Other assets	(14,192)	(6,393)
Accounts payable	(29,372)	(21,133)
Accrued liabilities	33,634	12,105
Deferred revenue, current and noncurrent	(30,937)	(226,829)
Customer deposits, current and noncurrent	(140,162)	102,100
Other noncurrent liabilities	7,071	(6,836)
Net cash used in operating activities	(278,320)	(500,048)
Investing activities
Purchases of property and equipment	(7,475)	(10,947)
Purchase of equity method investment	(2,500)
Net cash used in investing activities	(9,975)	(10,947)
Financing activities
Proceeds from the issuance of common stock, net of issuance costs	942,529	100,000
Proceeds from issuance of debt, net of issuance costs	199,369
Principal payments on borrowings	(400,000)
Proceeds from the exercise of common stock options	79,473	9,337
Repurchase of common stock	(3,777)	(7,073)
Proceeds from the sale of redeemable convertible preferred stock		7,500
Redemption of redeemable convertible preferred stock		(168,000)
Other financing activities	(250)	(1,198)
Net cash provided by (used in) financing activities	817,344	(59,434)
Effect of foreign exchange on cash, cash equivalents, and restricted cash	(678)	(2,992)
Net increase (decrease) in cash, cash equivalents, and restricted cash	528,371	(573,421)
Cash, cash equivalents, and restricted cash—beginning of period	1,401,962	1,266,835
Cash, cash equivalents, and restricted cash—end of period	1,930,333	693,414
Supplemental disclosures of cash flow information:
Cash paid for income taxes	9,143	1,981
Cash paid for interest	9,737
Supplemental disclosures of non-cash investing and financing information:
Receivable from the exercise of common stock options included in prepaid expenses and other current assets	36,557
Accrued purchase of property and equipment	461
Convertible Preferred Stock [Member]
Supplemental disclosures of non-cash investing and financing information:
Conversion of stock	10,810	7,375
Redeemable Convertible Preferred Stock [Member]
Supplemental disclosures of non-cash investing and financing information:
Conversion of stock		26,069
Conversion of Redeemable Convertible Preferred Stock into Convertible Preferred Stock [Member]
Supplemental disclosures of non-cash investing and financing information:
Conversion of stock		$ 4,163
Conversion of Redeemable Convertible Preferred Stock to Common Stock [Member]
Supplemental disclosures of non-cash investing and financing information:
Conversion of stock	2,138,988
Conversion Of Convertible Preferred Stock Warrants Into Common Stock Warrants [Member]
Supplemental disclosures of non-cash investing and financing information:
Conversion of stock	$ 31,007

Organization

Organization	9 Months Ended
	Sep. 30, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization	1. Organization Palantir Technologies Inc. (including its subsidiaries, “Palantir,” or “the Company”) was incorporated in Delaware on May 6, 2003. The Company builds and deploys software platforms, Palantir Gotham and Palantir Foundry, that serve as the central operating systems for its customers. Direct Listing On September 30, 2020, the Company completed a direct listing of its Class A common stock (the “Direct Listing”) on the New York Stock Exchange (“NYSE”). In connection with the Direct Listing, on September 22, 2020, the Company filed an amended and restated certificate of incorporation, which became effective on that date. The amended and restated certificate of incorporation authorized the issuance of a total of 20,000,000,000 shares of Class A common stock and 2,700,000,000 shares of Class B common stock, authorized 1,005,000 shares of a new class of common stock (“Class F common stock”) and 2,000,000,000 shares of undesignated preferred stock. In connection with the Direct Listing, Alexander Karp, Stephen Cohen, and Peter Thiel (the “Founders”) each transferred 335,000 shares of their Class B common stock to a voting trust, which were then exchanged for an equivalent number of shares of Immediately prior to the filing of the amended and restated certificate of incorporation, all outstanding shares of redeemable convertible preferred stock and convertible preferred stock were converted into 797,743,185 shares of the Company’s Class B common stock, and all of the Company’s outstanding preferred stock warrants were converted into common stock warrants, which resulted in the reclassification of the warrants liability to additional paid-in Furthermore, upon the occurrence of the Direct Listing, the Company determined that the performance-based vesting condition was satisfied for 68,149,214 restricted stock units (“RSUs”), which resulted in the issuance of an equivalent number of shares of Class A common stock. See further discussion in Note 11. Stock-Based Compensation

Significant Accounting Policies

Significant Accounting Policies	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Significant Accounting Policies [Text Block]	2. Significant Accounting Policies Basis of Presentation and Consolidation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. The accompanying condensed consolidated financial statements include the accounts of Palantir Technologies Inc. and its consolidated subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. Investments in entities where the Company holds at least a 20% ownership interest and has the ability to exercise significant influence over the investee, but does not control, are accounted for using the equity method of accounting. For such investments, the share of the investee’s results of operations is included as a component of other income (expense), net in the condensed consolidated statements of operations and the investment balance is included in other assets and classified as noncurrent in the condensed consolidated balance sheets. The Company’s fiscal year ends on December 31. The unaudited condensed consolidated balance sheet as of December 31, 2019 included herein was derived from the audited consolidated financial statements as of that date, but does not include all disclosures, including certain notes required by GAAP on an annual reporting basis. In management’s opinion, the unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the balance sheets and statements of operations, comprehensive loss, stockholders’ equity (deficit), and cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year or any future period. These unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s final prospectus filed with the SEC pursuant to Rule 424(b) under the Securities Act of 1933, as amended, on September 30, 2020 (the “Prospectus”). Use of Estimates The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Significant estimates and assumptions made in the accompanying condensed consolidated financial statements include, but are not limited to, identification of performance obligations in customer contracts, the fair value of common stock and other assumptions used to measure stock-based compensation, the fair value of preferred and common stock warrants, the valuation of deferred tax assets and uncertain tax positions, collectability of accounts receivable, and useful lives of tangible assets. Estimates and judgments are based on historical experience, forecasted events, and various other assumptions that management believes to be reasonable under the circumstances. Actual results could differ from those estimates and such differences could affect the Company’s financial position and results of operations. Summary of Significant Accounting Policies The Company’s significant accounting policies are discussed in Note 2. Significant Accounting Policies Cash, Cash Equivalents, and Restricted Cash The Company considers all highly liquid investments purchased with an original maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents consists of amounts invested in money market funds. Restricted cash primarily consists of cash and certificates of deposit that are held as collateral against letters of credit and guarantees that the Company is required to maintain for operating lease agreements, certain customer contracts, other guarantees, and financing arrangements. The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the amounts shown in the condensed consolidated statements of cash flows (in thousands): As of September 30, 2020 2019 Cash and cash equivalents $ 1,800,190 $ 507,319 Restricted cash 43,800 72,219 Restricted cash, noncurrent 86,343 113,876 Total cash, cash equivalents, and restricted cash $ 1,930,333 $ 693,414 Concentrations of Credit Risk and Other Concentrations Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents, restricted cash, and accounts receivable. Cash equivalents consist of money market funds with original maturities of three months or less, which are invested primarily with U.S. financial institutions. Cash deposits with financial institutions, including restricted cash, generally exceed federally insured limits. Management believes minimal credit risk exists with respect to these financial institutions and the Company has not experienced any losses on such amounts. The Company is exposed to concentrations of credit risk with respect to accounts receivable presented on the condensed consolidated balance sheets. The Company’s accounts receivable balance as of September 30, 2020 and December 31, 2019 was $162.3 million and $50.3 million, respectively. Customers E and H represented 15% and 11% of total accounts receivable as of September 30, 2020. Customers A and C represented 38% and 21% of total accounts receivable as of December 31, 2019, respectively. No other customer comprised more than 10% of total accounts receivable as of September 30, 2020 and December 31, 2019. The Company seeks to mitigate its credit risk with respect to accounts receivable by contracting with large commercial customers and government agencies and regularly monitoring the aging of accounts receivable balances. As of September 30, 2020 and December 31, 2019, the Company had not experienced any significant losses on its accounts receivable. For the three months ended September 30, 2020, no customer represented more than 10% of total revenue. For the nine months ended September 30, 2020, Customer F (in the government operating segment) represented 11% of total revenue. For the three and nine months ended September 30, 2019, Customer D (in the commercial operating segment) represented 12% and 13% of total revenue, respectively. No other customer represented more than 10% of total revenue for the three and nine months ended September 30, 2020 or 2019. The Company relies on the technology, infrastructure, and software applications, including software-as-a-service Recently Adopted Accounting Pronouncements As of September 30, 2020, the Company qualified as an emerging growth company (“EGC”) under the Jumpstart Our Business Startups Act (“JOBS Act”) which permits the Company an extended transition period for complying with new or revised accounting standards affecting public companies. The Company adopted the following accounting standard during the nine months ended September 30, 2020: Accounting Standard Update (“ASU”) 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement. 2018-13 Note 4. Fair Value Measurements Recently Issued Accounting Pronouncements In February 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-02, Leases (Topic 842) right-of-use right-of-use In June 2016, the FASB amended guidance related to impairment of financial instruments as part of ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments In August 2018, the FASB issued ASU 2018-15, Intangibles – Goodwill and Other – Internal-Use 350-40): internal-use 350-40 In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes (Topic 740)

Revenue Recognition

Revenue Recognition	9 Months Ended
	Sep. 30, 2020
Revenue from Contract with Customer [Abstract]
Revenue Recognition	3. Revenue Recognition Contract Balances The Company’s contract liabilities consist of deferred revenue and customer deposits. The changes in the Company’s contract liabilities were as follows (in thousands): Nine Months Ended Balance, beginning of period $ 794,811 Billings and other (1) 608,033 Revenue recognized (770,582 ) Refunds accrued or paid to customers (10,000 ) Balance, end of period $ 622,262 (1)    Remaining Performance Obligations The Company’s arrangements with its customers often have terms that span over multiple years. However, the Company generally allows its customers to terminate contracts for convenience prior to the end of the stated term with less than twelve months’ notice. Revenue allocated to remaining performance obligations represents noncancelable contracted revenue that has not yet been recognized, which includes deferred revenue and, in certain instances, amounts that will be invoiced. The Company has elected the practical expedient allowing the Company to not disclose remaining performance obligations for contracts with original terms of twelve months or less. Cancelable contracted revenue, which includes customer deposits, is not considered a remaining performance obligation. The Company’s remaining performance obligations were $321.6 million as of September 30, 2020, of which the Company expects to recognize approximately 58% as revenue over the next twelve months. Disaggregation of Revenue See Note 14. Segment and Geographic Information

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2020
Fair Value Disclosures [Abstract]
Fair Value Measurements	4. Fair Value Measurements Financial instruments consist of cash equivalents, restricted cash, accounts receivable, other assets accounted for at fair value, accounts payable, accrued liabilities, and warrants liability. Cash equivalents, restricted cash, and warrants liability are stated at fair value on a recurring basis. Accounts receivable, accounts payable, and accrued liabilities are stated at their carrying value, which approximates fair value due to the short time to the expected receipt or payment date. The carrying amount of the Company’s outstanding debt approximates the fair value as the debt bears a floating rate that approximates the market interest rate. The following table presents the Company’s assets and liabilities that are measured at fair value on a recurring and nonrecurring basis and indicates the fair value hierarchy of the valuation (in thousands): As of September 30, 2020 Total Level 1 Level 2 Level 3 Assets: Cash equivalents: Money market funds $ 980,254 $ 980,254 $ — $ — Restricted cash: Certificates of deposit 80,912 — 80,912 — Total $ 1,061,166 $ 980,254 $ 80,912 $ — As of December 31, 2019 Total Level 1 Level 2 Level 3 Assets: Cash equivalents: Money market funds $ 650,498 $ 650,498 $ — $ — Restricted cash: Certificates of deposit 102,904 — 102,904 — Prepaid expenses and other current assets: Assets held for sale 980 — — 980 Total $ 754,382 $ 650,498 $ 102,904 $ 980 Liabilities: Warrants liability $ 42,628 $ — $ — $ 42,628 Total $ 42,628 $ — $ — $ 42,628 Certificates of Deposit The Company’s Level 2 instruments consist of restricted cash invested in certificates of deposit. The fair value of such instruments are estimated based on valuations obtained from third-party pricing services that utilize industry standard valuation models, including both income-based and market-based approaches, for which all significant inputs are observable either directly or indirectly. These inputs include interest rate curves, foreign exchange rates, and credit ratings. Gross unrealized gains or losses for cash equivalents as of September 30, 2020 and December 31, 2019 were not material. Warrants Liability In connection with the completion of the Company’s Direct Listing, all of the outstanding warrants to purchase shares of redeemable convertible and convertible preferred stock converted into warrants to purchase shares of Class B common stock. As a result, the Company reclassified the warrants liability to additional paid-in paid-in For the year ended December 31, 2019, the warrants liability was included in other noncurrent liabilities in the condensed consolidated balance sheet and the fair value of the warrant liability was estimated using a combination of an option-pricing model and a Monte Carlo simulation model with equal weighting applied to both models in determining the fair values. These models consider many assumptions, including the likelihood of various potential liquidity events, the nature and timing of such potential events, actions taken with regard to the warrants at expiration, as well as discounts for lack of marketability of the underlying securities and warrants. The assumptions used to calculate the warrants liability as of September 29, 2020, the date immediately before the Direct Listing, and December 31, 2019 were as follows: September 29, December 31, Discounts for lack of marketability — 20.0% - 28.0% Fair value of underlying securities $9.50 $6.81 - $8.04 Expected volatility 66.0% 66.0% Dividend rate — — Risk-free interest rate 0.1% 1.3% The following table sets forth a summary of the changes in the estimated fair value of the Company’s warrants liability (in thousands): Balance as of December 31, 2019 $ 42,628 Net exercises in the period (10,810 ) Change in fair value of warrants (811 ) Reclassification to additional paid-in (31,007 ) Balance as of September 30, 2020 $ —

Balance Sheet Components

Balance Sheet Components	9 Months Ended
	Sep. 30, 2020
Balance Sheet Related Disclosures [Abstract]
Balance Sheet Components	5. Balance Sheet Components Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consisted of the following (in thousands): As of September 30, As of December 31, Equity related withholding tax and exercise proceeds receivable $ 339,409 $ — Other prepaid expenses and current assets 48,756 32,585 Total prepaid expenses and other current assets $ 388,165 $ 32,585 Property and Equipment, Net Property and equipment, net consisted of the following (in thousands): As of September 30, As of December 31, Leasehold improvements $ 88,198 $ 93,530 Computer equipment, software, and other 18,722 32,757 Furniture and fixtures 9,596 10,753 Construction in progress 5,817 3,161 Total property and equipment, gross 122,333 140,201 Less: accumulated depreciation and amortization (92,964 ) (108,612 ) Total property and equipment, net $ 29,369 $ 31,589 Depreciation and amortization expense related to property and equipment, net was $2.5 million and $3.1 million for the three months ended September 30, 2020 and 2019, respectively, and $9.3 million and $9.5 million for the nine months ended September 30, 2020 and 2019, respectively. Accrued Liabilities Accrued liabilities consisted of the following (in thousands): As of September 30, As of December 31, Accrued payroll and related expenses (1) $ 342,191 $ 31,355 Accrued other liabilities 124,808 95,265 Total accrued liabilities $ 466,999 $ 126,620 (1)   Includes $302.9 million owed by the Company for equity related employee withholding taxes related to the Direct Listing.

Equity Method Investments

Equity Method Investments	9 Months Ended
	Sep. 30, 2020
Equity Method Investments and Joint Ventures [Abstract]
Equity Method Investments	6. Equity Method Investments Palantir Technologies Japan, K.K. During November 2019, the Company and SOMPO Holdings, Inc. (“SOMPO”) created a Japanese Kabushiki Kaisha (“K.K.”), Palantir Technologies Japan, K.K. (“Palantir Japan”) to distribute Palantir platforms to the Japanese market. Upon closing of the transaction with SOMPO, the Company purchased a total of 100,000 shares of Palantir Japan common stock for $25.0 million. The shares the Company received in exchange represent a 50% voting interest in Palantir Japan. The remaining 50% of the voting interest is held by SOMPO. The Company’s investment in Palantir Japan is accounted for as an equity method investment as the Company is able to exercise significant influence over, but does not control, the investee. The Company recorded a $25.9 million initial investment in Palantir Japan, of which $0.9 million was related to direct costs incurred in connection with the transaction. The Company’s 50% share of profits or losses generated from Palantir Japan are reported on a quarter lag. The Company recorded $0.5 million and $1.4 million share of losses during the three and nine months ended September 30, 2020. Concurrently with the formation of Palantir Japan, the Company entered into a ten-year non-transferable In connection with the license rights sold to Palantir Japan, the Company recorded the receipt of the $25.0 million in deferred revenue which will be recognized over the term of the agreement. The Company recorded the $50.0 million service credit in deferred revenue, which will be utilized on an as-needed

Debt

Debt	9 Months Ended
	Sep. 30, 2020
Debt Disclosure [Abstract]
Debt	7. Debt 2014 Credit Facility In October 2014, the Company entered into an unsecured revolving credit facility (the “2014 Credit Facility”). The 2014 Credit Facility bears interest at the London Interbank Offered Rate (“LIBOR”) plus a margin of 2.75% per annum, subject to certain adjustments, and incurs a commitment fee of 0.375% assessed on the daily average undrawn portion of revolving commitments. Interest and commitment fees are payable at the end of an interest period or at each three-month interval if the interest period is longer than three months. In December 2019, the Company entered into an amendment to the 2014 Credit Facility to include an additional $150.0 million term loan and secured the credit facility with substantially all of the Company’s assets. Upon entering into this amendment, the Company drew down the $150.0 million term loan and $150.0 million under the existing revolving credit facility. The term loan portion of the 2014 Credit Facility was fully repaid and terminated as of December 31, 2019. In June 2020, the Company amended the 2014 Credit Facility to include a $150.0 million term loan, extend the maturity date to June 4, 2023, and add an additional lender. Additionally, this amendment increased the requirement to maintain minimum liquidity to $50.0 million, and provided the Company with an option to increase the total commitments by up to an additional $200.0 million, subject to the lenders’ approval. All other terms and conditions remained substantially the same upon the effectiveness of the amendment. Upon entering into this amendment, the Company drew down the total available term loan commitment of $150.0 million. In July 2020, the Company entered into another amendment to the 2014 Credit Facility, which added an additional lender and provided for an increase of $50.0 million to the revolving credit facility and a $50.0 million term loan. The incremental commitments were provided under the same terms as the existing commitments under the 2014 Credit Facility. During July 2020, the Company drew down the additional available term loan of $50.0 million and repaid the $150.0 million outstanding revolving credit facility. As of September 30, 2020, the Company had a $200.0 million term loan outstanding under the 2014 Credit Facility and an additional $200.0 million undrawn revolving credit facility available. The 2014 Credit Facility contains customary representations and warranties, and certain financial and nonfinancial covenants, including but not limited to maintaining minimum liquidity of $50.0 million, and certain limitations on liens and indebtedness. The Company was in compliance with all covenants associated with the 2014 Credit Facility as of September 30, 2020. 2019 Credit Facility On December 31, 2019, the Company entered into a senior secured revolving credit facility (the “2019 Credit Facility”) with a second lender. The 2019 Credit Facility allowed for the drawdown of up to $250.0 million. Amounts outstanding under the 2019 Credit Facility incurred interest at LIBOR plus a margin of 2.0% per annum, subject to certain adjustments. Interest was payable at the end of an interest period or at each three-month interval if the interest period was longer than three months. The 2019 Credit Facility also required the Company to maintain 50% of the aggregate revolving commitment in a specified collateral account, which was reported in restricted cash, noncurrent on the condensed consolidated balance sheets. As of December 31, 2019, the Company had $250.0 million outstanding and elected to incur interest at three-month LIBOR plus 2.0%. During June 2020, the outstanding balance was fully repaid and the 2019 Credit Facility was terminated, which released all restrictions on the cash collateral. The Company’s outstanding debt consisted of the following as of September 30, 2020 and December 31, 2019 (in thousands): As of September 30, 2020 As of December 31, Principal amount $ 200,000 $ 400,000 Unamortized discount (2,247 ) (3,935 ) Carrying value of debt $ 197,753 $ 396,065

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2020
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	8. Commitments and Contingencies Lease Commitments As of September 30, 2020, the majority of the Company’s leases were classified as operating. The Company leases office space under noncancelable operating leases with various expiration dates through March 2032. Certain of the Company’s operating leases contain renewal options and rent acceleration clauses. During the three months ended September 30, 2020 and 2019, net rent expense was $8.3 million and $10.4 million, respectively, which includes sublease income of $4.5 million and $3.7 million, respectively. During the nine months ended September 30, 2020 and 2019, net rent expense was $26.8 million and $26.0 million, respectively, and sublease income was $13.9 million and $10.5 million, respectively. Future annual minimum payments under noncancelable operating leases as of September 30, 2020 were as follows (in thousands): Operating Lease Commitments Less: Sublease Income Net Operating Lease Remainder 2020 $ 11,846 $ 4,352 $ 7,494 2021 46,209 17,582 28,627 2022 44,753 18,393 26,360 2023 44,015 18,288 25,727 2024 41,068 16,407 24,661 Thereafter 169,543 85,612 83,931 Total minimum lease payments $ 357,434 $ 160,634 $ 196,800 Letters of Credit and Guarantees The Company had irrevocable standby letters of credit and guarantees, including bank guarantees, outstanding in the amounts of $130.1 million and $322.8 million as of September 30, 2020 and December 31, 2019, respectively, which were fully collateralized. The Company is required to maintain these letters of credit and guarantees primarily for the 2019 Credit Facility, operating lease agreements, certain customer contracts, and other guarantees and financing arrangements. As a result of the 2019 Credit Facility being terminated during June 2020, as described in Note 7. Debt Purchase Commitments In December 2019, the Company entered into a minimum annual commitment to purchase cloud hosting services of at least $1.49 billion over six contract years, with an optional seventh carryover year, effective beginning January 1, 2020, in exchange for various discounts on such services. If the spend does not meet the minimum annual commitment each year or at the end of the term, the Company is obligated to make a return payment. If the difference is greater than $30.0 million for each of the first three contract years or $50.0 million for each of the contract years thereafter (“relief amounts”), the Company has the option to pay the respective relief amount for that year for services to be utilized in the future and the excess amount of the difference above the relief amount would be added to the minimum annual commitment of the following year through the end of the contract. As of September 30, 2020, the Company had satisfied $60.0 million of its $126.0 million commitment for the year ending December 31, 2020. If the Company is required to pay the $30.0 million relief amount it will be recorded as a prepayment for future cloud hosting services when due. The difference between the commitment and the amount satisfied will also be added to the Company’s commitment for the year ended December 31, 2021. In June 2020, the Company entered into a commitment to purchase at least $45.0 million of cloud hosting services over a period of five years commencing on June 1, 2020 and ending on May 31, 2025. If the spend commitment is not met at the end of the term, the Company is obligated to pay the full amount of the outstanding balance (“shortfall payment”). The shortfall payment may be applied as a prepayment against consumption, including to purchase reserved instances, during an additional twelve-month coverage period expiring on May 31, 2026, at which time any unused amount would be forfeited. As of September 30, 2020, the Company had satisfied $1.6 million of its commitment. Litigation and Legal Proceedings From time to time, third parties may assert patent infringement claims against the Company. In addition, from time to time, the Company may be subject to other legal proceedings and claims in the ordinary course of business, including claims of alleged infringement of trademarks, copyrights, and other intellectual property rights; employment claims; securities claims; investor claims; corporate claims; class action claims; and general contract, tort, or other claims. The Company may from time to time also be subject to various legal or government claims, disputes, or investigations. Such matters may include, but not be limited to, claims, disputes, allegations, or investigations related to warranty; refund; breach of contract; breach, leak, or misuse of personal data or confidential information; employment; government procurement; intellectual property; government regulation or compliance (including but not limited to anti-corruption requirements, export or other trade controls, data privacy or data protection, cybersecurity requirements, or antitrust/competition law requirements); securities; investor; corporate; or other matters. The Company is unable to predict whether or when any such matters may arise, the outcome of these matters, or the ultimate legal and financial liability, and cannot reasonably estimate the possible loss or range of loss at this time and accordingly has not accrued a related liability. On December 14, 2017, members of KT4 Partners LLC (Managing Member Marc Abramowitz) and Sandra Martin Clark, as trustee for the Marc Abramowitz Irrevocable Trust Number 7 (together, “KT4 Plaintiffs”) filed an action in the Delaware Superior Court against the Company and Disruptive Technology Advisers LLC. The complaint alleges tortious interference with prospective economic advantage and civil conspiracy in connection with a potential sale of stock by the KT4 Plaintiffs to a third party. The KT4 Plaintiffs seek compensatory and punitive damages, interest, fees, and costs. On August 30, 2019, BTIG, LLC (the “BTIG Plaintiff”), the alleged broker of the potential sale of stock that is the subject of the KT4 Plaintiffs’ December 2017 action, filed an action in the Delaware Superior Court against the Company and Disruptive Technology Advisers LLC. The complaint alleges tortious interference with prospective economic advantage and civil conspiracy in connection with the same potential sale of stock at issue in the KT4 Plaintiffs’ action by a group of sellers purportedly represented by the BTIG Plaintiff to a third party. The BTIG Plaintiff is seeking compensatory and punitive damages, interest, fees, and costs. The Company believes these lawsuits are without merit and is vigorously defending itself against them. Given the uncertainty of litigation it may be reasonably possible that the Company will incur a loss with regards to these matters; however, it cannot currently estimate a range of possible losses. Accordingly, the Company is unable at this time to estimate the overall effects that may result from these cases on its financial condition, results of operations, or cash flows. As of September 30, 2020 and December 31, 2019, the Company was not aware of any currently pending legal matters or claims, individually or in the aggregate, that are expected to have a material adverse impact on its condensed consolidated financial statements. Warranties and Indemnification The Company generally provides a warranty for its software products and services and a service level agreement (“SLA”) for the Company’s performance of software operations via its operations and maintenance (“O&M”) services to its customers. The Company’s products are generally warranted to perform substantially as described in the associated product documentation during the subscription term or for a period of up to 90 days where the software is hosted by the customer; and the Company includes O&M services as part of its subscription and license agreements to support this warranty and maintain the operability of the software. The Company’s services are generally warranted to be performed in a professional manner and by an adequate staff with knowledge about the products. In the event there is a failure of such warranties, the Company generally is obligated to correct the product or service to conform to the warranty provision, as set forth in the applicable SLA, or, if the Company is unable to do so, the customer is entitled to seek a refund of the purchase price of the product and service (generally prorated over the contract term). Due to the absence of historical warranty claims, the Company’s expectations of future claims related to products under warranty continue to be insignificant. The Company has not recorded warranty expense or related accruals as of September 30, 2020 and December 31, 2019. The Company generally agrees to indemnify its customers against legal claims that the Company’s software products infringe certain third-party intellectual property rights and accounts for its indemnification obligations. In the event of such a claim, the Company is generally obligated to defend its customer against the claim and to either settle the claim at the Company’s expense or pay damages that the customer is legally required to pay to the third-party claimant. In addition, in the event of an infringement, the Company generally agrees to secure the right for the customer to continue using the infringing product; to modify or replace the infringing product; or, if those options are not commercially practicable, to refund the cost of the software, as prorated over the period. To date, the Company has not been required to make any payment resulting from infringement claims asserted against its customers and does not believe that the Company will be liable for such claims in the foreseeable future. As such, the Company has not recorded a liability for infringement costs as of September 30, 2020 and December 31, 2019. The Company has obligations under certain circumstances to indemnify each of the defendant directors and certain officers against judgments, fines, settlements, and expenses related to claims against such directors and certain officers and otherwise to the fullest extent permitted under the law and the Company’s bylaws and Amended and Restated Certificate of Incorporation. Contingent Compensation During 2008, the Company formed a retention plan for certain employees and other service providers that were previously focused on the development of certain products of the Company relating to the financial industry (“Retention Plan”). The Company had not accrued any amounts under the Retention Plan, as of December 31, 2019 as payments were contingent on future events that were not considered probable. During August 2020, the Company’s Board of Directors determined no amounts were payable under the Retention Plan and the Retention Plan was terminated.

Stockholders' Deficit

Stockholders' Deficit	9 Months Ended
	Sep. 30, 2020
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure	9. Stockholders’ Equity (Deficit) During September 2020, the Company filed an amended and restated certificate of incorporation, which became effective on the date of its filing. The amended and restated certificate of incorporation authorized the issuance of a total of 20,000,000,000 shares of Class A common stock, 2,700,000,000 shares of Class B common stock, 1,005,000 shares of Class F common stock, and 2,000,000,000 shares of undesignated preferred stock. Substantially concurrently with the filing and acceptance of the amended and restated certificate of incorporation in connection with the Direct Listing, each of the Founders exchanged 335,000 shares of their Class B common stock for an equivalent number of shares of Class F common stock. The Company’s Class A, Class B, and Class F common stock all have the same rights, except with respect to voting and conversion rights. Class A and Class B common stock have voting rights of 1 and 10 votes per share, respectively. The Class F common stock has a variable number of votes and is convertible at any time, at the option of the holder thereof, into one share of Class B common stock. All shares of Class F common stock are held by a voting trust established by the Founders. The Class F common stock generally give the Founders the ability to control up to 49.999999% of the total voting power of the Company’s capital stock, so long as the Founders and certain of their affiliates collectively meet a minimum ownership threshold, which was 100.0 million of the Company’s equity securities as of September 30, 2020. Holders of Class A, Class B, and Class F common stock are entitled to dividends when, as and, if declared by the Company’s Board of Directors, subject to the rights of the holders of all classes of stock outstanding having priority rights to dividends. No dividends have been declared as of September 30, 2020. During the nine months ended September 30, 2020 the Company sold a total of 206,500,523 shares of its Class A common stock at a price of $4.65 per share, for aggregate proceeds of $942.5 million, net of issuance costs of $17.7 million. Included in these sales were 107,526,881 shares of Class A common stock sold to SOMPO, a partner investor in the Company’s equity method investee, Palantir Japan. In connection with the Direct Listing in September 2020, all outstanding shares of redeemable convertible preferred stock and convertible preferred stock were converted into 4,017,378 and 793,725,807 shares of Class B common stock, respectively, and 1,005,000 shares of Class B common stock held by the Founders were exchanged for an equal number of shares of Class F common stock. The following represented the total authorized, issued, and outstanding shares for each class of common stock: As of September 30, 2020 As of December 31, 2019 Authorized Issued Outstanding Authorized Issued Outstanding Common stock: Class A 20,000,000,000 1,320,584,721 1,320,584,721 2,200,000,000 315,615,753 309,223,182 Class B 2,700,000,000 405,096,034 405,096,034 1,800,000,000 272,273,934 272,273,934 Class F 1,005,000 1,005,000 1,005,000 — — — Total 22,701,005,000 1,726,685,755 1,726,685,755 4,000,000,000 587,889,687 581,497,116 Treasury Stock On April 30, 2020, the Board of Directors approved the retirement of all shares of treasury stock. Retirement of treasury stock was recorded as a reduction of common stock and additional paid-in

Warrants

Warrants	9 Months Ended
	Sep. 30, 2020
Warrants and Rights Note Disclosure [Abstract]
Warrants	10. Warrants During the three months ended September 30, 2020, a warrant for 2,586,208 shares of Series D preferred stock with a strike price of $0.7406 was cashless exercised and net settled into 2,380,034 shares of Series D convertible preferred stock. Additionally, a warrant for 7,632,154 shares of Class B common stock with a strike price of $0.001 was cashless exercised and net settled into 7,631,329 shares of Class B common stock. Upon the effectiveness of the amended and restated certificate of incorporation filed in connection with the Direct Listing, all of the outstanding preferred stock warrants were converted into common stock warrants. As a result of the conversion, the warrants became equity-classified and the warrants liability was reclassified to additional paid-in As of September 30, 2020, warrants outstanding include warrants to purchase 5,211,093 shares of Class B common stock with a strike price of $6.13 per share, and warrants to purchase 814,666 shares of Class B common stock with a strike price of $3.51 per share. The warrants expire in between December 2021 to January 2025. In addition, the Company has warrants outstanding to purchase up to 13,042,415 shares of Class B common stock that will be automatically net exercised upon a Qualifying IPO, which did not include the Company’s Direct Listing, and only if the valuation of the Company immediately prior to such IPO (“IPO Valuation”) is less than $12.9 billion. These warrants expire in November 2023 and, as of September 30, 2020, were considered not probable of vesting.

Stock-Based Compensation

Stock-Based Compensation	9 Months Ended
	Sep. 30, 2020
Share-based Payment Arrangement [Abstract]
Stock-Based Compensation	11. Stock-Based Compensation 2010 Equity Incentive Plan In 2010, the Company adopted the 2010 Equity Incentive Plan, as amended from time to time (“Amended 2010 Equity Incentive Plan”, or “2010 Plan”). The 2010 Plan permitted the granting of incentive stock options (“ISOs”), non-statutory The 2010 Plan was terminated prior to the Company’s Direct Listing, and no additional awards will be granted under the 2010 Plan. However, the 2010 Plan will continue to govern the terms and conditions of the outstanding awards previously granted under the 2010 Plan. 2020 Executive Equity Incentive Plan In August 2020, the Company’s Board of Directors approved the 2020 Executive Equity Incentive Plan (the “Executive Equity Plan”). The Executive Equity Plan permitted the granting NSOs and RSUs to the Company’s employees, consultants, and directors. A total of 165,900,000 shares of the Company’s Class B common stock were reserved for issuance under the Executive Equity Plan. During August 2020, options to purchase 162,000,000 shares of Class B common stock and restricted stock units covering 3,900,000 shares of the Company’s Class B common stock were granted to certain officers and all were outstanding as of September 30, 2020. The Executive Equity Plan was terminated prior to the Company’s Direct Listing, and no additional awards will be granted under the Executive Equity Plan. However, the Executive Equity Plan will continue to govern the terms and conditions of the outstanding awards previously granted under the Executive Equity Plan. 2020 Equity Incentive Plan In September 2020, prior to the Direct Listing, the Company’s Board of Directors approved the 2020 Equity Incentive Plan (“2020 Plan”). The 2020 Plan provides for the grant of ISOs, NSOs, restricted stock, RSUs, SARs, and performance awards to the Company’s employees, directors, and consultants. A total of 150,000,000 shares of the Company’s Class A common stock are reserved for issuance pursuant to the 2020 Plan. In addition, the number of shares of Class A common stock reserved for issuance under the 2020 Plan includes the number of shares of Class A common stock or Class B common stock subject to awards under the Company’s Amended 2010 Equity Incentive Plan and Executive Equity Plan. Shares of Class B common stock added to the 2020 Plan from the 2010 Plan or Executive Equity Plan are reserved for issuance under the Company’s 2020 Plan as Class A common stock. The number of shares of Class A common stock available for issuance under the 2020 Plan will also include an annual increase on the first day of each fiscal year beginning on January 1, 2022, equal to the least of: • 250,000,000 shares of the Company’s Class A common stock; • Five percent (5%) of the outstanding shares of the Company’s common stock as of the last day of the immediately preceding fiscal year; or • such other amount as the administrator of the 2020 Plan determines. Under the 2020 Plan, the exercise price of options granted is generally at least equal to the fair market value of the Company’s Class A common stock on the date of grant. The term of an ISO generally may not exceed ten years. Additionally, the exercise price of any ISO granted to a 10% stockholder shall not be less than 110% of the estimated fair value of the common stock on the date of grant, and the term of such option grant shall not exceed five years. Options and other equity awards become vested and, if applicable, exercisable based on terms determined by the Board of Directors or an other plan administrator on the date of grant, which is typically five years for new employees and varies for subsequent grants. Stock Options The following table summarizes stock option activity for the nine months ended September 30, 2020 (in thousands, except share and per share amounts): Options Weighted- Exercise Price Weighted- Remaining Aggregate Balance as of December 31, 2019 497,441,159 $ 4.10 5.81 $ 975,798 Options granted (1) 397,885,337 7.43 Options exercised (69,444,099 ) 1.67 Options canceled and forfeited (1) (238,005,542 ) 5.95 Balance as of September 30, 2020 587,876,855 $ 5.89 7.99 $ 2,120,561 Options vested and exercisable as of September 30, 2020 344,033,233 $ 3.64 5.90 $ 2,014,537 (1) Includes options that were canceled and re-granted As of September 30, 2020, the unrecognized expense related to options outstanding was $1.2 billion, which is expected to be recognized over a weighted-average service period of 8.07 years. Additionally, as of September 30, 2020, there were 100,000 cash-settled SARs outstanding and exercisable at an exercise price of $2.70 per share. No SARs were granted during the nine months ended September 30, 2020. Stock Option Modifications During the nine months ended September 30, 2020, the Company modified 37,451,458 fully vested and outstanding options that were approaching expiration. The extension of the original options was recorded as a stock option modification whereby the incremental fair value of each option was determined at the date of the modification and $9.4 million was immediately recognized related to vested options. The weighted average extended term for the modified options was approximately 0.46 years. In June 2020, the Company repriced 235,885,337 stock options. As part of the repricing, the original options were canceled and new options were granted with an exercise price of $4.72 per share and a remaining contractual term of ten years. The new options were generally subject to the same service-based vesting schedule as the original options. The repricing was recorded as a stock option modification whereby the incremental fair value of each option was determined at the date of the modification and $74.0 million was immediately recognized related to vested options in June 2020 and an additional $4.5 million was recognized during the three months ended September 30, 2020. As of September 30, 2020, there was remaining incremental fair value of $27.0 million which will be recognized over the remaining requisite service period. RSUs The following table summarizes the RSU activity for the nine months ended September 30, 2020: RSUs Weighted Average Grant Date Fair Value per Share Unvested and outstanding as of December 31, 2019 179,494,619 $ 6.03 RSUs granted 96,707,758 7.49 RSUs vested (68,149,214 ) 6.18 RSUs canceled (8,397,930 ) 6.02 Unvested and outstanding at September 30, 2020 199,655,233 $ 6.69 The performance-based vesting condition for all RSUs was satisfied upon the Company’s Direct Listing, September 30, 2020. Upon such satisfaction, 68,149,214 RSUs, for which the service-based vesting condition was met as of such date, vested and converted into an equivalent number of shares of Class A common stock. As a result, the Company recognized $769.5 million in cumulative stock-based compensation expense using the accelerated attribution method from the grant date. As of September 30, 2020, the total unrecognized stock-based compensation expense related to the RSUs outstanding was $1.0 billion, which the Company expects to recognize over 3.13 years. Growth Units In May 2019, the Company granted growth units which vest upon the satisfaction of both a performance-based vesting condition, which was satisfied upon the Company’s Direct Listing, and a service-based vesting condition. Growth units have a formula used to calculate the number of shares of the Company’s common stock that would be earned by the holder upon the satisfaction of all vesting criteria. Upon the Direct Listing, the Company recognized $8.4 million in cumulative stock-based compensation expense using the accelerated attribution method from the service start date through the effective date of the Direct Listing. As of September 30, 2020, the total unrecognized stock-based compensation expense related to the 3,582,674 growth units outstanding was $2.4 million, which the Company expects to recognize over the remainder of the 180-day 180-day Stock-based Compensation Expense Total stock-based compensation expense was as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 Cost of revenue $ 94,385 $ 7,183 $ 120,285 $ 16,520 Sales and marketing 263,958 15,898 322,353 56,242 Research and development 256,769 15,031 309,698 49,137 General and administrative 231,847 13,651 276,578 42,751 Total stock-based compensation expense $ 846,959 $ 51,763 $ 1,028,914 $ 164,650 Related Party Non-Recourse In November 2016, the Company entered into a non-recourse In August 2020, the Company received a payment of $26.6 million for a portion of the principal and accrued interest on the outstanding non-recourse

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2020
Income Tax Disclosure [Abstract]
Income Taxes	12. Income Taxes The Company recorded a benefit from income taxes of $8.5 million and a provision (benefit) for income taxes $2.0 million for the three months ended September 30, 2020 and 2019, respectively, and a benefit from income taxes of $5.0 million and a provision (benefit) for income taxes of $8.5 million for the nine months ended September 30, 2020 and 2019, respectively. The Company is subject to income tax in the U.S. as well as other tax jurisdictions in which it conducts business. The change in provision (benefit) for income taxes was primarily due to decreases in profits from the Company’s international operations, benefits from stock-based compensation windfalls, and the revaluation of its United Kingdom (“UK”) deferred tax assets as a result of a change in the UK corporate tax rate enacted during the current quarter. The realization of deferred tax assets is dependent upon the generation of sufficient taxable income of the appropriate character in future periods. The Company assesses its ability to realize the deferred tax assets on a quarterly basis and it establishes a valuation allowance if it is more-likely-than-not non-deductible The Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) was enacted on March 27, 2020 in the United States. The CARES Act and related notices include several significant provisions, including delaying certain payroll tax payments, mandatory transition tax payments under the Tax Cut and Jobs Act, and estimated income tax payments that the Company is deferring to future periods. The CARES Act did not have a material impact on the Company’s financial results, including on its annual estimated effective tax rate or on its liquidity. The Company will continue to monitor and assess the impact the CARES Act and similar legislation in other countries may have on its business and financial results.

Net Loss Per Share Attributable

Net Loss Per Share Attributable to Common Stockholders	9 Months Ended
	Sep. 30, 2020
Earnings Per Share [Abstract]
Net Loss Per Share Attributable to Common Stockholders	13. Net Loss Per Share Attributable to Common Stockholders The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except share and per share amounts): Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 Numerator Net loss attributable to common stockholders $ (853,319 ) $ (139,860 ) $ (1,018,048 ) $ (420,319 ) Less: Change in fair value attributable to participating securities — — (5,483 ) — Net loss attributable to common stockholders, for diluted net loss per share $ (853,319 ) $ (139,860 ) $ (1,023,531 ) $ (420,319 ) Denominator Weighted-average shares used in computing net loss per share, basic 905,462,010 580,104,846 713,879,104 574,342,061 Weighted-average shares used in computing net loss per share, diluted 905,462,010 580,104,846 716,027,459 574,342,061 Net loss per share Net loss per share attributable to common stockholders, basic $ (0.94 ) $ (0.24 ) $ (1.43 ) $ (0.73 ) Net loss per share attributable to common stockholders, diluted $ (0.94 ) $ (0.24 ) $ (1.43 ) $ (0.73 ) The following outstanding potentially dilutive common stock equivalents have been excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented due to their anti-dilutive effect: As of September 30, 2020 2019 Redeemable convertible preferred stock — 4,017,378 Convertible preferred stock — 794,336,186 Warrants to purchase redeemable convertible and convertible preferred stock — 21,831,545 Warrants to purchase common stock 19,068,174 993,266 Options and SARs issued and outstanding 587,976,855 470,352,024 RSUs outstanding 199,655,233 — Growth units outstanding 3,582,674 22,377,040 Total 810,282,936 1,313,907,439

Segment and Geographic Informat

Segment and Geographic Information	9 Months Ended
	Sep. 30, 2020
Segment Reporting [Abstract]
Segment and Geographic Information	14. Segment and Geographic Information The following reporting segment tables reflect the results of the Company’s reportable operating segments consistent with the manner in which the chief operating decision maker (“CODM”) evaluates the performance of each segment and allocates the Company’s resources. The CODM does not evaluate the performance of the Company’s assets on a segment basis for internal management reporting and, therefore, such information is not presented. Contribution is used, in part, to evaluate the performance of, and allocate resources to, each of the segments. Segment contribution is segment revenue less the related costs of revenue and sales and marketing expenses. It excludes certain operating expenses that are not allocated to segments because they are separately managed at the consolidated corporate level. These unallocated costs include stock-based compensation expense, research and development expenses, and general and administrative expenses. Financial information for each reportable segment was as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 Revenue: Government $ 162,561 $ 96,801 $ 420,257 $ 242,843 Commercial 126,805 93,740 350,325 270,354 Total revenue $ 289,366 $ 190,541 $ 770,582 $ 513,197 Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 Contribution: Government $ 93,962 $ 23,934 $ 226,186 $ 46,614 Commercial 69,496 4,949 168,908 35,619 Total segment contribution $ 163,458 $ 28,883 $ 395,094 $ 82,233 The reconciliation of segment financial information to loss from operations is as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 Loss from operations $ (847,777 ) $ (144,140 ) $ (1,017,107 ) $ (428,993 ) Research and development expenses (1) 57,146 60,849 156,832 180,591 General and administrative expenses (1) 107,130 60,411 226,455 165,985 Stock-based compensation expense 846,959 51,763 1,028,914 164,650 Segment contribution $ 163,458 $ 28,883 $ 395,094 $ 82,233 (1) Excludes stock-based compensation expense. Geographic Information Revenue by geography is based on the customer’s headquarters or agency location at the time of sale. Revenue is as follows (in thousands, except percentages): Three Months Ended September 30, 2020 2019 Amount % Amount % Revenue: United States $ 156,336 54 % $ 79,185 42 % United Kingdom 35,432 12 % 29,765 16 % France 23,214 8 % 16,930 9 % Rest of world (1) 74,384 26 % 64,661 33 % Total revenue $ 289,366 100 % $ 190,541 100 % (1) No other country represents 10% or more of total revenue for the three months ended September 30, 2020 or 2019. Nine Months Ended September 30, 2020 2019 Amount % Amount % Revenue: United States $ 391,106 51 % $ 197,351 38 % United Kingdom 94,440 12 % 89,384 17 % France 78,572 10 % 50,222 10 % Rest of world (1) 206,464 27 % 176,240 35 % Total revenue $ 770,582 100 % $ 513,197 100 % (1) No other country represents 10% or more of total revenue for the nine months ended September 30, 2020 or 2019 .

Significant Accounting Polici_2

Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Basis of Presentation and Consolidation	Basis of Presentation and Consolidation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. The accompanying condensed consolidated financial statements include the accounts of Palantir Technologies Inc. and its consolidated subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation. Investments in entities where the Company holds at least a 20% ownership interest and has the ability to exercise significant influence over the investee, but does not control, are accounted for using the equity method of accounting. For such investments, the share of the investee’s results of operations is included as a component of other income (expense), net in the condensed consolidated statements of operations and the investment balance is included in other assets and classified as noncurrent in the condensed consolidated balance sheets. The Company’s fiscal year ends on December 31. The unaudited condensed consolidated balance sheet as of December 31, 2019 included herein was derived from the audited consolidated financial statements as of that date, but does not include all disclosures, including certain notes required by GAAP on an annual reporting basis. In management’s opinion, the unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary to present fairly the balance sheets and statements of operations, comprehensive loss, stockholders’ equity (deficit), and cash flows for the interim periods, but are not necessarily indicative of the results of operations to be anticipated for the full fiscal year or any future period. These unaudited consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s final prospectus filed with the SEC pursuant to Rule 424(b) under the Securities Act of 1933, as amended, on September 30, 2020 (the “Prospectus”).
Use of Estimates	Use of Estimates The preparation of the condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenue and expenses during the reporting periods. Significant estimates and assumptions made in the accompanying condensed consolidated financial statements include, but are not limited to, identification of performance obligations in customer contracts, the fair value of common stock and other assumptions used to measure stock-based compensation, the fair value of preferred and common stock warrants, the valuation of deferred tax assets and uncertain tax positions, collectability of accounts receivable, and useful lives of tangible assets. Estimates and judgments are based on historical experience, forecasted events, and various other assumptions that management believes to be reasonable under the circumstances. Actual results could differ from those estimates and such differences could affect the Company’s financial position and results of operations.
Cash, Cash Equivalents, and Restricted Cash	Cash, Cash Equivalents, and Restricted Cash The Company considers all highly liquid investments purchased with an original maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents consists of amounts invested in money market funds. Restricted cash primarily consists of cash and certificates of deposit that are held as collateral against letters of credit and guarantees that the Company is required to maintain for operating lease agreements, certain customer contracts, other guarantees, and financing arrangements. The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the amounts shown in the condensed consolidated statements of cash flows (in thousands): As of September 30, 2020 2019 Cash and cash equivalents $ 1,800,190 $ 507,319 Restricted cash 43,800 72,219 Restricted cash, noncurrent 86,343 113,876 Total cash, cash equivalents, and restricted cash $ 1,930,333 $ 693,414
Concentrations of Credit Risk and Other Concentrations	Concentrations of Credit Risk and Other Concentrations Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash, cash equivalents, restricted cash, and accounts receivable. Cash equivalents consist of money market funds with original maturities of three months or less, which are invested primarily with U.S. financial institutions. Cash deposits with financial institutions, including restricted cash, generally exceed federally insured limits. Management believes minimal credit risk exists with respect to these financial institutions and the Company has not experienced any losses on such amounts. The Company is exposed to concentrations of credit risk with respect to accounts receivable presented on the condensed consolidated balance sheets. The Company’s accounts receivable balance as of September 30, 2020 and December 31, 2019 was $162.3 million and $50.3 million, respectively. Customers E and H represented 15% and 11% of total accounts receivable as of September 30, 2020. Customers A and C represented 38% and 21% of total accounts receivable as of December 31, 2019, respectively. No other customer comprised more than 10% of total accounts receivable as of September 30, 2020 and December 31, 2019. The Company seeks to mitigate its credit risk with respect to accounts receivable by contracting with large commercial customers and government agencies and regularly monitoring the aging of accounts receivable balances. As of September 30, 2020 and December 31, 2019, the Company had not experienced any significant losses on its accounts receivable. For the three months ended September 30, 2020, no customer represented more than 10% of total revenue. For the nine months ended September 30, 2020, Customer F (in the government operating segment) represented 11% of total revenue. For the three and nine months ended September 30, 2019, Customer D (in the commercial operating segment) represented 12% and 13% of total revenue, respectively. No other customer represented more than 10% of total revenue for the three and nine months ended September 30, 2020 or 2019. The Company relies on the technology, infrastructure, and software applications, including software-as-a-service
Recently Adopted and Issued Accounting Pronouncements	Recently Adopted Accounting Pronouncements As of September 30, 2020, the Company qualified as an emerging growth company (“EGC”) under the Jumpstart Our Business Startups Act (“JOBS Act”) which permits the Company an extended transition period for complying with new or revised accounting standards affecting public companies. The Company adopted the following accounting standard during the nine months ended September 30, 2020: Accounting Standard Update (“ASU”) 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement. 2018-13 Note 4. Fair Value Measurements Recently Issued Accounting Pronouncements In February 2016, the Financial Accounting Standards Board (“FASB”) issued ASU 2016-02, Leases (Topic 842) right-of-use right-of-use In June 2016, the FASB amended guidance related to impairment of financial instruments as part of ASU 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments In August 2018, the FASB issued ASU 2018-15, Intangibles – Goodwill and Other – Internal-Use 350-40): internal-use 350-40 In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes (Topic 740)

Significant Accounting Polici_3

Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2020
Accounting Policies [Abstract]
Schedule of Cash and Cash Equivalents	The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the amounts shown in the condensed consolidated statements of cash flows (in thousands): As of September 30, 2020 2019 Cash and cash equivalents $ 1,800,190 $ 507,319 Restricted cash 43,800 72,219 Restricted cash, noncurrent 86,343 113,876 Total cash, cash equivalents, and restricted cash $ 1,930,333 $ 693,414

Revenue Recognition (Tables)

Revenue Recognition (Tables)	9 Months Ended
	Sep. 30, 2020
Revenue from Contract with Customer [Abstract]
Summary Of Contract Liabilities, Consist Of Total Deferred Revenue And Customer Deposits	The Company’s contract liabilities consist of deferred revenue and customer deposits. The changes in the Company’s contract liabilities were as follows (in thousands): Nine Months Ended Balance, beginning of period $ 794,811 Billings and other (1) 608,033 Revenue recognized (770,582 ) Refunds accrued or paid to customers (10,000 ) Balance, end of period $ 622,262 (1)

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2020
Fair Value Disclosures [Abstract]
Summary Of Assets And Liabilities That Are Measured At Fair Value On A Recurring And Nonrecurring Basis	The following table presents the Company’s assets and liabilities that are measured at fair value on a recurring and nonrecurring basis and indicates the fair value hierarchy of the valuation (in thousands): As of September 30, 2020 Total Level 1 Level 2 Level 3 Assets: Cash equivalents: Money market funds $ 980,254 $ 980,254 $ — $ — Restricted cash: Certificates of deposit 80,912 — 80,912 — Total $ 1,061,166 $ 980,254 $ 80,912 $ — As of December 31, 2019 Total Level 1 Level 2 Level 3 Assets: Cash equivalents: Money market funds $ 650,498 $ 650,498 $ — $ — Restricted cash: Certificates of deposit 102,904 — 102,904 — Prepaid expenses and other current assets: Assets held for sale 980 — — 980 Total $ 754,382 $ 650,498 $ 102,904 $ 980 Liabilities: Warrants liability $ 42,628 $ — $ — $ 42,628 Total $ 42,628 $ — $ — $ 42,628
Summary Of Warrants Liability	The assumptions used to calculate the warrants liability as of September 29, 2020, the date immediately before the Direct Listing, and December 31, 2019 were as follows: September 29, December 31, Discounts for lack of marketability — 20.0% - 28.0% Fair value of underlying securities $9.50 $6.81 - $8.04 Expected volatility 66.0% 66.0% Dividend rate — — Risk-free interest rate 0.1% 1.3%
Disclosure Summary Of Changes In Fair Value Of Warrants Liability	The following table sets forth a summary of the changes in the estimated fair value of the Company’s warrants liability (in thousands): Balance as of December 31, 2019 $ 42,628 Net exercises in the period (10,810 ) Change in fair value of warrants (811 ) Reclassification to additional paid-in (31,007 ) Balance as of September 30, 2020 $ —

Balance Sheet Components (Table

Balance Sheet Components (Tables)	9 Months Ended
	Sep. 30, 2020
Balance Sheet Related Disclosures [Abstract]
Prepaid Expenses and Other Current Assets	Prepaid expenses and other current assets consisted of the following (in thousands): As of September 30, As of December 31, Equity related withholding tax and exercise proceeds receivable $ 339,409 $ — Other prepaid expenses and current assets 48,756 32,585 Total prepaid expenses and other current assets $ 388,165 $ 32,585
Schedule of Property and Equipment, Net	Property and equipment, net consisted of the following (in thousands): As of September 30, As of December 31, Leasehold improvements $ 88,198 $ 93,530 Computer equipment, software, and other 18,722 32,757 Furniture and fixtures 9,596 10,753 Construction in progress 5,817 3,161 Total property and equipment, gross 122,333 140,201 Less: accumulated depreciation and amortization (92,964 ) (108,612 ) Total property and equipment, net $ 29,369 $ 31,589 Depreciation and amortization expense related to property and equipment, net was $2.5 million and $3.1 million for the three months ended September 30, 2020 and 2019, respectively, and $9.3 million and $9.5 million for the nine months ended September 30, 2020 and 2019, respectively.
Schedule of Accrued Liabilities	Accrued liabilities consisted of the following (in thousands): As of September 30, As of December 31, Accrued payroll and related expenses (1) $ 342,191 $ 31,355 Accrued other liabilities 124,808 95,265 Total accrued liabilities $ 466,999 $ 126,620 (1)   Includes $302.9 million owed by the Company for equity related employee withholding taxes related to the Direct Listing.

Debt (Tables)

Debt (Tables)	9 Months Ended
	Sep. 30, 2020
Debt Disclosure [Abstract]
Summary of outstanding debt	The Company’s outstanding debt consisted of the following as of September 30, 2020 and December 31, 2019 (in thousands): As of September 30, 2020 As of December 31, Principal amount $ 200,000 $ 400,000 Unamortized discount (2,247 ) (3,935 ) Carrying value of debt $ 197,753 $ 396,065

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2020
Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]
Summary of future annual minimum payments under noncancelable operating leases	Future annual minimum payments under noncancelable operating leases as of September 30, 2020 were as follows (in thousands): Operating Lease Commitments Less: Sublease Income Net Operating Lease Remainder 2020 $ 11,846 $ 4,352 $ 7,494 2021 46,209 17,582 28,627 2022 44,753 18,393 26,360 2023 44,015 18,288 25,727 2024 41,068 16,407 24,661 Thereafter 169,543 85,612 83,931 Total minimum lease payments $ 357,434 $ 160,634 $ 196,800

Stockholders' Deficit (Tables)

Stockholders' Deficit (Tables)	9 Months Ended
	Sep. 30, 2020
Stockholders' Equity Note [Abstract]
Summary of Total Authorized, Issued, And Outstanding Shares	The following represented the total authorized, issued, and outstanding shares for each class of common stock: As of September 30, 2020 As of December 31, 2019 Authorized Issued Outstanding Authorized Issued Outstanding Common stock: Class A 20,000,000,000 1,320,584,721 1,320,584,721 2,200,000,000 315,615,753 309,223,182 Class B 2,700,000,000 405,096,034 405,096,034 1,800,000,000 272,273,934 272,273,934 Class F 1,005,000 1,005,000 1,005,000 — — — Total 22,701,005,000 1,726,685,755 1,726,685,755 4,000,000,000 587,889,687 581,497,116

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2020
Share-based Payment Arrangement [Abstract]
Summary of Stock Option Activity	The following table summarizes stock option activity for the nine months ended September 30, 2020 (in thousands, except share and per share amounts): Options Weighted- Exercise Price Weighted- Remaining Aggregate Balance as of December 31, 2019 497,441,159 $ 4.10 5.81 $ 975,798 Options granted (1) 397,885,337 7.43 Options exercised (69,444,099 ) 1.67 Options canceled and forfeited (1) (238,005,542 ) 5.95 Balance as of September 30, 2020 587,876,855 $ 5.89 7.99 $ 2,120,561 Options vested and exercisable as of September 30, 2020 344,033,233 $ 3.64 5.90 $ 2,014,537 (1) Includes options that were canceled and re-granted
Summary of RSU Activity	The following table summarizes the RSU activity for the nine months ended September 30, 2020: RSUs Weighted Average Grant Date Fair Value per Share Unvested and outstanding as of December 31, 2019 179,494,619 $ 6.03 RSUs granted 96,707,758 7.49 RSUs vested (68,149,214 ) 6.18 RSUs canceled (8,397,930 ) 6.02 Unvested and outstanding at September 30, 2020 199,655,233 $ 6.69
Summary of Stock-Based Compensation Expense	Total stock-based compensation expense was as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 Cost of revenue $ 94,385 $ 7,183 $ 120,285 $ 16,520 Sales and marketing 263,958 15,898 322,353 56,242 Research and development 256,769 15,031 309,698 49,137 General and administrative 231,847 13,651 276,578 42,751 Total stock-based compensation expense $ 846,959 $ 51,763 $ 1,028,914 $ 164,650

Net Loss Per Share Attributab_2

Net Loss Per Share Attributable to Common Stockholders (Tables)	9 Months Ended
	Sep. 30, 2020
Earnings Per Share [Abstract]
Summary of Calculation of Basic and Diluted Net Loss Per Share	The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders (in thousands, except share and per share amounts): Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 Numerator Net loss attributable to common stockholders $ (853,319 ) $ (139,860 ) $ (1,018,048 ) $ (420,319 ) Less: Change in fair value attributable to participating securities — — (5,483 ) — Net loss attributable to common stockholders, for diluted net loss per share $ (853,319 ) $ (139,860 ) $ (1,023,531 ) $ (420,319 ) Denominator Weighted-average shares used in computing net loss per share, basic 905,462,010 580,104,846 713,879,104 574,342,061 Weighted-average shares used in computing net loss per share, diluted 905,462,010 580,104,846 716,027,459 574,342,061 Net loss per share Net loss per share attributable to common stockholders, basic $ (0.94 ) $ (0.24 ) $ (1.43 ) $ (0.73 ) Net loss per share attributable to common stockholders, diluted $ (0.94 ) $ (0.24 ) $ (1.43 ) $ (0.73 )
Summary of Antidilutive Securities	The following outstanding potentially dilutive common stock equivalents have been excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented due to their anti-dilutive effect: As of September 30, 2020 2019 Redeemable convertible preferred stock — 4,017,378 Convertible preferred stock — 794,336,186 Warrants to purchase redeemable convertible and convertible preferred stock — 21,831,545 Warrants to purchase common stock 19,068,174 993,266 Options and SARs issued and outstanding 587,976,855 470,352,024 RSUs outstanding 199,655,233 — Growth units outstanding 3,582,674 22,377,040 Total 810,282,936 1,313,907,439

Segment and Geographic Inform_2

Segment and Geographic Information (Tables)	9 Months Ended
	Sep. 30, 2020
Segment Reporting [Abstract]
Summary of Financial Information for Each Reportable Segment	Financial information for each reportable segment was as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 Revenue: Government $ 162,561 $ 96,801 $ 420,257 $ 242,843 Commercial 126,805 93,740 350,325 270,354 Total revenue $ 289,366 $ 190,541 $ 770,582 $ 513,197 Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 Contribution: Government $ 93,962 $ 23,934 $ 226,186 $ 46,614 Commercial 69,496 4,949 168,908 35,619 Total segment contribution $ 163,458 $ 28,883 $ 395,094 $ 82,233
Summary of Reconciliation of Segment Financial Information to Loss from Operations	The reconciliation of segment financial information to loss from operations is as follows (in thousands): Three Months Ended September 30, Nine Months Ended September 30, 2020 2019 2020 2019 Loss from operations $ (847,777 ) $ (144,140 ) $ (1,017,107 ) $ (428,993 ) Research and development expenses (1) 57,146 60,849 156,832 180,591 General and administrative expenses (1) 107,130 60,411 226,455 165,985 Stock-based compensation expense 846,959 51,763 1,028,914 164,650 Segment contribution $ 163,458 $ 28,883 $ 395,094 $ 82,233 (1) Excludes stock-based compensation expense.
Summary of Revenue by Geography	Revenue by geography is based on the customer’s headquarters or agency location at the time of sale. Revenue is as follows (in thousands, except percentages): Three Months Ended September 30, 2020 2019 Amount % Amount % Revenue: United States $ 156,336 54 % $ 79,185 42 % United Kingdom 35,432 12 % 29,765 16 % France 23,214 8 % 16,930 9 % Rest of world (1) 74,384 26 % 64,661 33 % Total revenue $ 289,366 100 % $ 190,541 100 % (1) No other country represents 10% or more of total revenue for the three months ended September 30, 2020 or 2019. Nine Months Ended September 30, 2020 2019 Amount % Amount % Revenue: United States $ 391,106 51 % $ 197,351 38 % United Kingdom 94,440 12 % 89,384 17 % France 78,572 10 % 50,222 10 % Rest of world (1) 206,464 27 % 176,240 35 % Total revenue $ 770,582 100 % $ 513,197 100 % (1) No other country represents 10% or more of total revenue for the nine months ended September 30, 2020 or 2019 .

Organization - Additional Infor

Organization - Additional Information (Detail) - shares	3 Months Ended	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2020	Dec. 31, 2019
Stockholders' Equity Attributable to Parent [Abstract]
Common stock, shares authorized	22,701,005,000	22,701,005,000	4,000,000,000
Preferred stock, shares authorized	2,000,000,000	2,000,000,000	0
Common Class A [Member]
Stockholders' Equity Attributable to Parent [Abstract]
Common stock, shares authorized	20,000,000,000	20,000,000,000	2,200,000,000
Common Class B [Member]
Stockholders' Equity Attributable to Parent [Abstract]
Common stock, shares authorized	2,700,000,000	2,700,000,000	1,800,000,000
Number of shares issued for conversion		335,000
Common Class F [Member]
Stockholders' Equity Attributable to Parent [Abstract]
Common stock, shares authorized	1,005,000	1,005,000	0
Common Stock [Member]
Stockholders' Equity Attributable to Parent [Abstract]
Common stock shares issued upon conversion of convertible preferred stock	797,743,185	797,743,185
Issuance of common stock upon settlement of restricted stock units ("RSUs"), Shares	68,149,214

Significant Accounting Polici_4

Significant Accounting Policies - Schedule of Cash and Cash Equivalents (Detail) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019	Sep. 30, 2019	Dec. 31, 2018
Accounting Policies [Abstract]
Cash and cash equivalents	$ 1,800,190	$ 1,079,154	$ 507,319
Restricted cash	43,800	52,099	72,219
Restricted cash, noncurrent	86,343	270,709	113,876
Total cash, cash equivalents, and restricted cash	$ 1,930,333	$ 1,401,962	$ 693,414	$ 1,266,835

Significant Accounting Polici_5

Significant Accounting Policies - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Accounts receivable	$ 162,269		$ 162,269		$ 50,315
Accounts Receivable [Member] | Customer A [Member]
Percentage Concentration					38.00%
Accounts Receivable [Member] | Customer C [Member]
Percentage Concentration					21.00%
Accounts Receivable [Member] | Customer E [Member]
Percentage Concentration			15.00%
Accounts Receivable [Member] | Customer H [Member]
Percentage Concentration			11.00%
Revenue Benchmark [Member] | Customer F [Member]
Percentage Concentration			11.00%
Revenue Benchmark [Member] | Customer D [Member]
Percentage Concentration		12.00%		13.00%
Maximum [Member] | Accounts Receivable [Member]
Percentage Concentration			10.00%		10.00%
Maximum [Member] | Revenue Benchmark [Member]
Percentage Concentration	10.00%	10.00%	10.00%	10.00%

Revenue Recognition - Summary O

Revenue Recognition - Summary Of Contract Liabilities, Consist Of Total Deferred Revenue And Customer Deposits (Detail) $ in Thousands	9 Months Ended
	Sep. 30, 2020USD ($)
Revenue from Contract with Customer [Abstract]
Contract liabilities as of beginning balance	$ 794,811
Billings and other	608,033
Revenue recognized	(770,582)
Refunds accrued or paid to customers	(10,000)
Contract liabilities as of ending balance	$ 622,262

Revenue Recognition - Additiona

Revenue Recognition - Additional information (Detail) $ in Millions	Sep. 30, 2020USD ($)
Revenue from Contract with Customer [Abstract]
Performance obligation	$ 321.6
Performance obligation percentage to be recognised as revenue in the next twelve months	58.00%

Fair Value Measurements - Summa

Fair Value Measurements - Summary Of Assets And Liabilities That Are Measured At Fair Value On A Recurring And Nonrecurring Basis (Detail) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	$ 1,061,166	$ 754,382
Warrants liability	0	42,628
Total		42,628
Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	980,254	650,498
Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total	80,912	102,904
Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total		980
Total		42,628
Prepaid Expenses and Other Current Assets [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets held for sale		980
Prepaid Expenses and Other Current Assets [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets held for sale		980
Warrants Liability [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants liability		42,628
Warrants Liability [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants liability		42,628
Restricted Cash [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Certificates of deposit	80,912	102,904
Restricted Cash [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Certificates of deposit	80,912	102,904
Money Market Funds [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	980,254	650,498
Money Market Funds [Member] | Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash equivalents	$ 980,254	$ 650,498

Fair Value Measurements - Sum_2

Fair Value Measurements - Summary Of Warrants Liability (Detail)	Sep. 30, 2020$ / shares	Dec. 31, 2019$ / shares
Measurement Input, Discount for Lack of Marketability [Member] | Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement Input		0.28
Measurement Input, Discount for Lack of Marketability [Member] | Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement Input		0.2
Fair Value Of Underlying Securities [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement Input	$ 9.50
Fair Value Of Underlying Securities [Member] | Maximum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement Input		$ 8.04
Fair Value Of Underlying Securities [Member] | Minimum [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement Input		$ 6.81
Expected Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement Input	0.66	0.66
Risk-free Interest Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Measurement Input	0.001	0.013

Fair Value Measurements - Discl

Fair Value Measurements - Disclosure Summary Of Changes In Fair Value Of Warrants Liability (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Balance as of December 31, 2019			$ 42,628
Net exercises in the period			(10,810)
Change in fair value of warrants	$ 9,201	$ (784)	(811)	$ (2,743)
Reclassification to additional paid-in capital in result of conversion of preferred stock warrants to common stock warrants	31,007		31,007
Balance as of September 30, 2020	$ 0		0
Conversion Of Preferred Stock Warrants To Common Stock Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Reclassification to additional paid-in capital in result of conversion of preferred stock warrants to common stock warrants			$ (31,007)

Balance Sheet Components - Prep

Balance Sheet Components - Prepaid Expenses and Other Current Assets (Detail) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Balance Sheet Related Disclosures [Abstract]
Equity related withholding tax and exercise proceeds receivable	$ 339,409
Other prepaid expenses and current assets	48,756	$ 32,585
Total prepaid expenses and other current assets	$ 388,165	$ 32,585

Balance Sheet Components - Sche

Balance Sheet Components - Schedule of Property and Equipment, Net (Detail) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Balance Sheet Related Disclosures [Abstract]
Leasehold improvements	$ 88,198	$ 93,530
Computer equipment, software, and other	18,722	32,757
Furniture and fixtures	9,596	10,753
Construction in progress	5,817	3,161
Total property and equipment, gross	122,333	140,201
Less: accumulated depreciation and amortization	(92,964)	(108,612)
Total property and equipment, net	$ 29,369	$ 31,589

Balance Sheet Components - Sc_2

Balance Sheet Components - Schedule of Accrued Liabilities (Detail) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Balance Sheet Related Disclosures [Abstract]
Accrued payroll and related expenses	$ 342,191	$ 31,355
Accrued other liabilities	124,808	95,265
Total accrued liabilities	$ 466,999	$ 126,620

Balance Sheet Components - Sc_3

Balance Sheet Components - Schedule of Accrued Liabilities (Parenthetical) (Detail) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Balance Sheet Components [Line Items]
Employee taxes witheld and payable	$ 342,191	$ 31,355
Direct Listing [Member]
Balance Sheet Components [Line Items]
Employee taxes witheld and payable	$ 302,900

Balance Sheet Components - Addi

Balance Sheet Components - Additional information (Detail) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Balance Sheet Related Disclosures [Abstract]
Depreciation And Amortisation Expense Excluding The Impact Of Foreign Exchange Fluctuations	$ 2.5	$ 3.1	$ 9.3	$ 9.5

Equity Method Investments Addit

Equity Method Investments Additional information (Detail) - USD ($) $ in Thousands	Sep. 30, 2020	Nov. 30, 2019	Sep. 30, 2020	Sep. 30, 2020
Schedule of Equity Method Investments [Line Items]
Payments made to acquire equity method investments				$ 2,500
Share of profits or losses recorded				(1,439)
Service Credit Utilized			$ 900	1,900
Palantir Technologies Japan, K.K. [Member]
Schedule of Equity Method Investments [Line Items]
Number of shares purchased		100,000
Payments made to acquire equity method investments		$ 25,000
Equity method investment ownership percentage		50.00%
Initial investment recorded	$ 25,900	$ 900	25,900	25,900
Share of profits or losses recorded			$ (500)	(1,400)
Palantir Technologies Japan, K.K. [Member] | License and Service [Member]
Schedule of Equity Method Investments [Line Items]
License and services agreement Term		10 years
Palantir Technologies Japan, K.K. [Member] | Service Credit [Member]
Schedule of Equity Method Investments [Line Items]
Service Credit recognition expiry period		5 years
Palantir Technologies Japan, K.K. [Member] | Usage Of Trademark [Member] | License and Service [Member]
Schedule of Equity Method Investments [Line Items]
Amount paid in exchange for usage of trademark				25,000
Prepayment Amount received	$ 50,000
Service Credit Utilized				$ 50,000
SOMPO [Member]
Schedule of Equity Method Investments [Line Items]
Equity method investment ownership percentage		50.00%
Percentage Of Share Of Profits Or Losses Generated [Member]
Schedule of Equity Method Investments [Line Items]
Equity Method Investment, Additional Information				The Company’s 50% share of profits or losses generated from Palantir Japan are reported on a quarter lag.

Debt - Summary of outstanding d

Debt - Summary of outstanding debt (Detail) - USD ($) $ in Thousands	Sep. 30, 2020	Dec. 31, 2019
Debt Disclosure [Abstract]
Principal amount	$ 200,000	$ 400,000
Unamortized discount	(2,247)	(3,935)
Carrying value of debt	$ 197,753	$ 396,065

Debt - Additional Information (

Debt - Additional Information (Detail) - USD ($) $ in Thousands	Sep. 30, 2020	Jul. 31, 2020	Jun. 30, 2020	Dec. 31, 2019	Oct. 30, 2014	Dec. 31, 2019
Short-term Debt [Line Items]
Debt, noncurrent, net	$ 197,753			$ 396,065		$ 396,065
2014 Revolving Credit Facility [Member]
Short-term Debt [Line Items]
Line of credit facility commitment fee percentage					0.375%
Line of credit maximum borrowing capacity			$ 200,000
Line of credit maturity date			Jun. 4, 2023	Dec. 31, 2019
Proceeds from lines of credit						150,000
Repayments of lines of credit		$ 150,000
Undrawn revolving credit facility amount	200,000
2014 Revolving Credit Facility [Member] | Minimum [Member]
Short-term Debt [Line Items]
Line of credit minimum liquidity to be maintained	50,000		$ 50,000
2014 Revolving Credit Facility [Member] | Term Loan [Member]
Short-term Debt [Line Items]
Line of credit maximum borrowing capacity			150,000
Debt instrument, face amount				$ 150,000		150,000
Proceeds from lines of credit			$ 150,000			150,000
Line of credit, additional borrowing capacity		50,000
Debt instrument, additional borrowing capacity		50,000
Proceeds from long term debt		$ 50,000
Debt, noncurrent, net	$ 200,000
2014 Revolving Credit Facility [Member] | London Interbank Offered Rate (LIBOR) [Member]
Short-term Debt [Line Items]
Line of credit facility variable interest rate spread					2.75%
Line of credit facility variable interest rate description					London Interbank Offered Rate (''LIBOR'') plus a margin of 2.75%
2019 Revolving Credit Facility [Member]
Short-term Debt [Line Items]
Line of credit facility frequency of payment				Interest was payable at the end of an interest period or at each three-month interval if the interest period was longer than three months.
Line of credit maximum borrowing capacity				$ 250,000		250,000
Percentage of aggregate revolving commitment to be maintained				50.00%
Line of credit outstanding				$ 250,000		$ 250,000
2019 Revolving Credit Facility [Member] | London Interbank Offered Rate (LIBOR) [Member]
Short-term Debt [Line Items]
Line of credit facility variable interest rate spread				2.00%
Line of credit facility variable interest rate description				LIBOR plus a margin of 2.0% per annum

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) - USD ($) $ in Millions	1 Months Ended		3 Months Ended		9 Months Ended		12 Months Ended
	Jun. 30, 2020	Dec. 31, 2019	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Loss Contingencies [Line Items]
Net rent expense			$ 8.3	$ 10.4	$ 26.8	$ 26
Sublease income			4.5	$ 3.7	13.9	$ 10.5
Letter of credit outstanding amount		$ 322.8	130.1		$ 130.1		$ 322.8
Letters of credit and guarantees [Member]
Loss Contingencies [Line Items]
Line of credit termination date					Aug. 31, 2028		Aug. 31, 2028
Purchase Commitment One [Member]
Loss Contingencies [Line Items]
Minimum annual commitment		$ 1,490
Long-term Purchase Commitment, Description		If the difference is greater than $30.0 million for each of the first three contract years or $50.0 million for each of the contract years thereafter (“relief amounts”), the Company has the option to pay the respective relief amount for that year for services to be utilized in the future and the excess amount of the difference above the relief amount would be added to the minimum annual commitment of the following year through the end of the contract.
Satisfied purchase commitment					$ 60
Purchase Commitment One [Member] | Relief Amount For Future Cloud Hosting Services Member [Member]
Loss Contingencies [Line Items]
Relief amount payable in the future			$ 30		30
Purchase Commitment Two [Member]
Loss Contingencies [Line Items]
Minimum annual commitment	$ 45
Satisfied purchase commitment	$ 1.6				$ 126

Commitments and Contingencies_2

Commitments and Contingencies - Summary Of Future Annual Minimum Payments Under Noncancelable Operating Leases (Detail) $ in Thousands	Sep. 30, 2020USD ($)
Disclosure Of Future Annual Minimum Payments Under Noncancelable Operating Leases [Line Items]
Remainder 2020	$ 11,846
2021	46,209
2022	44,753
2023	44,015
2024	41,068
Thereafter	169,543
Total minimum lease payments	357,434
Remainder 2020	7,494
2021	28,627
2022	26,360
2023	25,727
2024	24,661
Thereafter	83,931
Total minimum lease payments	196,800
Sublease Income	160,634
Sub Lease Income Remainder Of Year [Member]
Disclosure Of Future Annual Minimum Payments Under Noncancelable Operating Leases [Line Items]
Sublease Income	4,352
Sub Lease Income Due Next Twelve Months [Member]
Disclosure Of Future Annual Minimum Payments Under Noncancelable Operating Leases [Line Items]
Sublease Income	17,582
Sub Lease Income Due In Two Years [Member]
Disclosure Of Future Annual Minimum Payments Under Noncancelable Operating Leases [Line Items]
Sublease Income	18,393
Sub Lease Income Due In Three Years [Member]
Disclosure Of Future Annual Minimum Payments Under Noncancelable Operating Leases [Line Items]
Sublease Income	18,288
Sub Lease Income Due In Four Years [Member]
Disclosure Of Future Annual Minimum Payments Under Noncancelable Operating Leases [Line Items]
Sublease Income	16,407
Sub Lease Income Due Thereafter [Member]
Disclosure Of Future Annual Minimum Payments Under Noncancelable Operating Leases [Line Items]
Sublease Income	$ 85,612

Stockholders' Deficit- Summary

Stockholders' Deficit- Summary Of Total Authorized, Issued, And Outstanding Shares (Detail) - shares	Sep. 30, 2020	Dec. 31, 2019
Class of Stock [Line Items]
Common stock, shares authorized	22,701,005,000	4,000,000,000
Common stock, shares issued	1,726,685,755	587,889,687
Common stock, shares outstanding	1,726,685,755	581,497,116
Common Class A [Member]
Class of Stock [Line Items]
Common stock, shares authorized	20,000,000,000	2,200,000,000
Common stock, shares issued	1,320,584,721	315,615,753
Common stock, shares outstanding	1,320,584,721	309,223,182
Common Class B [Member]
Class of Stock [Line Items]
Common stock, shares authorized	2,700,000,000	1,800,000,000
Common stock, shares issued	405,096,034	272,273,934
Common stock, shares outstanding	405,096,034	272,273,934
Common Class F [Member]
Class of Stock [Line Items]
Common stock, shares authorized	1,005,000	0
Common stock, shares issued	1,005,000	0
Common stock, shares outstanding	1,005,000	0

Stockholders' Deficit- Addition

Stockholders' Deficit- Additional Information (Detail) - USD ($)	9 Months Ended
	Sep. 30, 2020	Dec. 31, 2019
Common stock, shares authorized	22,701,005,000	4,000,000,000
Preferred stock, shares authorized	2,000,000,000	0
minimum ownership threshold	$ 100,000,000
Number of treasury stock	0	6,392,571
Dividends declared	$ 0
Common Class A [Member]
Common stock, shares authorized	20,000,000,000	2,200,000,000
Number of shares sold in the transaction	206,500,523
Sale price per share	$ 4.65
Proceeds from sale of equity	$ 942,500,000
Payment of stock issuance cost	$ 17,700,000
Common Class A [Member] | SOMPO [Member]
Number of shares sold in the transaction	107,526,881
Common Class B [Member]
Common stock, shares authorized	2,700,000,000	1,800,000,000
Number of shares issued for conversion	335,000
Number of shares exchanged	1,005,000
Common Class B [Member] | Redeemable Convertible Preferred Stock [Member]
Convertible Preferred Stock, Shares Issued upon Conversion	4,017,378
Common Class B [Member] | Convertible preferred stock [Member]
Convertible Preferred Stock, Shares Issued upon Conversion	793,725,807
Common Class F [Member]
Common stock, shares authorized	1,005,000	0
voting power	50.00%

Warrants - Additional Informati

Warrants - Additional Information (Detail) $ / shares in Units, $ in Billions	3 Months Ended	9 Months Ended
	Sep. 30, 2020USD ($)$ / sharesshares	Sep. 30, 2020USD ($)$ / sharesshares
Common Class B [Member] | Series I Lead [Member]
Class of Warrant or Right [Line Items]
Warrants outstanding	5,211,093	5,211,093
Exercise price of each warrant | $ / shares	$ 6.13	$ 6.13
Common Class B [Member] | Venture 13 Warrants [Member]
Class of Warrant or Right [Line Items]
Warrants outstanding	814,666	814,666
Exercise price of each warrant | $ / shares	$ 3.51	$ 3.51
Common Class B [Member] | Series I Lead Or Venture Thirteen Warrants [Member] | Maximum [Member]
Class of Warrant or Right [Line Items]
Class of warrant or right, expiration month and year		2025-01
Common Class B [Member] | Series I Lead Or Venture Thirteen Warrants [Member] | Minimum [Member]
Class of Warrant or Right [Line Items]
Class of warrant or right, expiration month and year		2021-12
Common Class B [Member] | Series I IPO [Member]
Class of Warrant or Right [Line Items]
Warrants outstanding	13,042,415	13,042,415
Class of warrant or right, expiration month and year		2023-11
Warrants and rights outstanding exercise contingency | $	$ 12.9	$ 12.9
Common Stock [Member]
Class of Warrant or Right [Line Items]
Issuance of common stock upon net exercise of common stock warrants shares	7,631,329	7,631,329
Warrants issued to purchase shares	7,632,154	7,632,154
Exercise price of each warrant | $ / shares	$ 0.001	$ 0.001
SeriesDConvertibleStock [Member]
Class of Warrant or Right [Line Items]
Warrants issued to purchase shares	2,586,208	2,586,208
Exercise price of each warrant | $ / shares	$ 0.7406	$ 0.7406
Stock shares issued during the period share	2,380,034

Stock-Based Compensation - Add

Stock-Based Compensation - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Thousands	Sep. 30, 2020	Aug. 30, 2020	Aug. 06, 2020	Jun. 30, 2020	Nov. 30, 2016	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Aug. 20, 2020
Share-based Compensation Arrangement by Share-based Payment Award, Plan Modification, Description and Terms								$ 7.43
Common shares issuable upon full vesting of the growth units			1,500,000
Cumulative stock-based compensation expense						$ 846,959	$ 51,763	$ 1,028,914	$ 164,650
Share based payment award expiration period and option contractual term								5 months 15 days
Percentage of outstanding stock maximum								5.00%
Options grants in period								397,885,337
Unrecognized share based compensation expense	$ 1,200,000					$ 1,200,000		$ 1,200,000
Unrecognized share based compensation expense, period for recognition			180 days					8 years 25 days
Non option equity instruments outstanding	3,582,674					3,582,674		3,582,674
Stock-based compensation						$ 8,400		$ 1,028,914	$ 164,650
2020 Executive Equity Incentive Plan [Member]
Shares reserved for future issuance										165,900,000
Options grants in period			162,000,000
2020 Extended Exercisability [Member]
Share based compensation arrangement by share based payment award plan modification								37,451,458
Share-based payment arrangement, plan modification, incremental cost								$ 9,400
2010 Plan [Member]
Share based payment award vesting period								5 years
Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting For Change in Control, Award Vesting Rights, Percentage								0.25
2020 Equity Incentive Plan [Member]
Percentage of ownership	10.00%					10.00%		10.00%
Share based payment award expiration period and option contractual term			10 years
Shares reserved for future issuance	150,000,000					150,000,000		150,000,000
Employee Director [Member]
Payments related to tax withholding								$ 800
Due to employees director current	$ 4,000					$ 4,000		$ 4,000
Stock-based compensation						4,500
Employee Director [Member] | Non Recourse Promissory Notes [Member]
Percentage of fixed interest					1.50%
Debt instrument, face amount					$ 25,900
Settlement Of Employee Loan			$ 26,600
Stock repurchased and retired during period, shares			3,500,000
Debt instrument decrease forgiveness			$ 800
Employee Director [Member] | Non Recourse Promissory Notes [Member] | Pledged Collateral [Member]
Number of common stock held as collateral					10,500,000
Share-based Payment Arrangement, Tranche Two [Member] | Officers [Member]
Share based payment award vesting period			5 years
June 2020 Reprice [Member]
Share-based payment arrangement, plan modification, incremental cost	$ 27,000			$ 74,000		$ 4,500
Number of shares repriced				235,885,337
Remaining contractual term of repriced options				10 years
June 2020 Reprice [Member] | Exercise Price of Repriced Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Plan Modification, Description and Terms				$ 4.72
Minimum [Member] | 2020 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent	110.00%					110.00%		110.00%
Common Class A [Member] | 2020 Equity Incentive Plan [Member]
Share-based payment award, number of additional shares authorized								250,000,000
Restricted Stock Units (RSUs) [Member]
Conversion of units to common stock								68,149,214
Cumulative stock-based compensation expense								$ 769,500
Unrecognized share based compensation expense	$ 1,000,000					$ 1,000,000		$ 1,000,000
Unrecognized share based compensation expense, period for recognition								3 years 1 month 17 days
Equity Instruments Other than Options, Grants in Period								96,707,758
Restricted Stock Units (RSUs) [Member] | 2020 Executive Equity Incentive Plan [Member]
Equity Instruments Other than Options, Grants in Period		3,900,000
Growth units [Member]
Unrecognized share based compensation expense	$ 2,400					$ 2,400		$ 2,400
Stock Appreciation Rights (SARs) [Member]
Non option equity instruments outstanding	100,000					100,000		100,000
Non option equity instruments exercise price								$ 2.70
Non option equity instruments grants in period								0

Stock-Based Compensation - Summ

Stock-Based Compensation - Summary of Stock Option Activity (Detail) $ / shares in Units, $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2020USD ($)$ / sharesshares	Dec. 31, 2019USD ($)$ / sharesshares
Share-based Payment Arrangement [Abstract]
Beginning Balance of Options Outstanding | shares	497,441,159
Options granted | shares	397,885,337
Options exercised | shares	(69,444,099)
Options canceled and forfeitedOptions canceled and forfeited | shares	(238,005,542)
Ending Balance of Options Outstanding | shares	587,876,855	497,441,159
Options vested and exercisable as of September 30, 2020 | shares	344,033,233
Beginning Balance of Weighted-Average Exercise Price Per Share | $ / shares	$ 4.10
Options granted | $ / shares	7.43
Options exercised | $ / shares	1.67
Options canceled and forfeited | $ / shares	5.95
Ending Balance of Weighted-Average Exercise Price Per Share | $ / shares	5.89	$ 4.10
Options vested and exercisable as of September 30, 2020 | $ / shares	$ 3.64
Weighted- Average Remaining Contractual Life (years)	7 years 11 months 26 days	5 years 9 months 21 days
Options vested and exercisable as of September 30, 2020	5 years 10 months 24 days
Beginning Balance of Aggregate Intrinsic Value | $		$ 975,798
Ending Balance of Aggregate Intrinsic Value | $	$ 2,120,561
Options vested and exercisable as of September 30, 2020 | $	$ 2,014,537

Stock-Based Compensation - Su_2

Stock-Based Compensation - Summary of RSU Activity (Detail) - Restricted Stock Units	9 Months Ended
	Sep. 30, 2020$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested and Outstanding Beginning Balance | shares	179,494,619
RSUs granted | shares	96,707,758
RSUs vested | shares	(68,149,214)
RSUs canceled | shares	(8,397,930)
Unvested and Outstanding Ending Balance | shares	199,655,233
Weighted Average Grant Date Fair Value per Share Beginning Balance | $ / shares	$ 6.03
RSUs granted | $ / shares	7.49
RSUs vested | $ / shares	6.18
RSUs canceled | $ / shares	6.02
Weighted Average Grant Date Fair Value per Share Ending Balance | $ / shares	$ 6.69

Stock-Based Compensation - Su_3

Stock-Based Compensation - Summary of Stock Based Compensation Expense (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	$ 846,959	$ 51,763	$ 1,028,914	$ 164,650
Cost of revenue [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	94,385	7,183	120,285	16,520
Sales and marketing [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	263,958	15,898	322,353	56,242
Research and development [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	256,769	15,031	309,698	49,137
General and administrative [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total stock-based compensation expense	$ 231,847	$ 13,651	$ 276,578	$ 42,751

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Income Tax Disclosure [Abstract]
Provision for income taxes	$ (8,543)	$ 2,026	$ (5,043)	$ 8,485

Net Loss Per Share Attributab_3

Net Loss Per Share Attributable to Common Stockholders - Summary of Calculation of Basic and Diluted Net Loss Per Share (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Numerator
Net loss attributable to common stockholders	$ (853,319)	$ (139,860)	$ (1,018,048)	$ (420,319)
Less: Change in fair value attributable to participating securities			(5,483)
Net loss attributable to common stockholders, for diluted net loss per share	$ (853,319)	$ (139,860)	$ (1,023,531)	$ (420,319)
Denominator
Weighted-average shares used in computing net loss per share, basic	905,462,010	580,104,846	713,879,104	574,342,061
Weighted-average shares used in computing net loss per share, diluted	905,462,010	580,104,846	716,027,459	574,342,061
Net loss per share
Net loss per share attributable to common stockholders, basic	$ (0.94)	$ (0.24)	$ (1.43)	$ (0.73)
Net loss per share attributable to common stockholders, diluted	$ (0.94)	$ (0.24)	$ (1.43)	$ (0.73)

Net Loss Per Share Attributab_4

Net Loss Per Share Attributable to Common Stockholders - Summary of Antidilutive Securities (Detail) - shares	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	810,282,936	1,313,907,439
Redeemable Convertible Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount		4,017,378
Convertible preferred stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount		794,336,186
Warrants to purchase redeemable convertible and convertible preferred stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount		21,831,545
Warrants to purchase common stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	19,068,174	993,266
Options and SARs issued and outstanding [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	587,976,855	470,352,024
RSUs outstanding [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	199,655,233
Growth units outstanding [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount	3,582,674	22,377,040

Segment and Geographic Inform_3

Segment and Geographic Information - Summary of Financial Information for Each Reportable Segment (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Segment Reporting Information [Line Items]
Revenues	$ 289,366	$ 190,541	$ 770,582	$ 513,197
Loss from operations	(847,777)	(144,140)	(1,017,107)	(428,993)
Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenues	289,366	190,541	770,582	513,197
Loss from operations	163,458	28,883	395,094	82,233
Government [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenues	162,561	96,801	420,257	242,843
Loss from operations	93,962	23,934	226,186	46,614
Commercial [Member] | Operating Segments [Member]
Segment Reporting Information [Line Items]
Revenues	126,805	93,740	350,325	270,354
Loss from operations	$ 69,496	$ 4,949	$ 168,908	$ 35,619

Segment and Geographic Inform_4

Segment and Geographic Information - Summary of Reconciliation of Segment Financial Information to Loss from Operations (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Segment Reporting Information [Line Items]
Research and development expenses	$ 313,915	$ 75,880	$ 466,530	$ 229,728
General and administrative expenses	338,977	74,062	503,033	208,736
Stock-based compensation expense	846,959	51,763	1,028,914	164,650
Loss from operations	(847,777)	(144,140)	(1,017,107)	(428,993)
Reconciling items
Segment Reporting Information [Line Items]
Research and development expenses	57,146	60,849	156,832	180,591
General and administrative expenses	107,130	60,411	226,455	165,985
Stock-based compensation expense	846,959	51,763	1,028,914	164,650
Operating Segments
Segment Reporting Information [Line Items]
Loss from operations	$ 163,458	$ 28,883	$ 395,094	$ 82,233

Segment and Geographic Inform_5

Segment and Geographic Information - Summary of Revenue by Geography (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Disaggregation of Revenue [Line Items]
Revenues	$ 289,366	$ 190,541	$ 770,582	$ 513,197
Geographic Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Revenues	$ 289,366	$ 190,541	$ 770,582	$ 513,197
Concentration risk, percentage	100.00%	100.00%	100.00%	100.00%
United States [Member] | Geographic Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Revenues	$ 156,336	$ 79,185	$ 391,106	$ 197,351
Concentration risk, percentage	54.00%	42.00%	51.00%	38.00%
United Kingdom [Member] | Geographic Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Revenues	$ 35,432	$ 29,765	$ 94,440	$ 89,384
Concentration risk, percentage	12.00%	16.00%	12.00%	17.00%
France [Member] | Geographic Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Revenues	$ 23,214	$ 16,930	$ 78,572	$ 50,222
Concentration risk, percentage	8.00%	9.00%	10.00%	10.00%
Rest of world [Member] | Geographic Concentration Risk [Member]
Disaggregation of Revenue [Line Items]
Revenues	$ 74,384	$ 64,661	$ 206,464	$ 176,240
Concentration risk, percentage	26.00%	33.00%	27.00%	35.00%

Segment and Geographic Inform_6

Segment and Geographic Information - Summary of Revenue by Geography (Parenthetical) (Detail)	3 Months Ended		9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019
Revenue Benchmark [Member] | Minimum [Member]
Disaggregation of Revenue [Line Items]
Concentration risk, percentage	10.00%	10.00%	10.00%	10.00%